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Summary 
Hematopoiesis, the dynamic process of blood cell development, is regulated by the 
activity of the Bone Morphogenetic Protein (BMP) signaling pathway, and many 
transcription factors.  However, the molecules and the mechanisms that regulate 
BMP/Smad signaling in hematopoiesis are largely unknown. In our study, we show that 
the Integrator complex, an evolutionarily conserved group of proteins, functions in 
zebrafish hematopoiesis by modulating Smad/BMP signaling. The Integrator complex 
proteins are known to directly interact with RNA polymerase II to mediate 3’end 
processing of U1 and U2 snRNAs. We have identified several subunits of the Integrator 
complex in zebrafish.  Anti-sense morpholino mediated knock-down of the Integrator 
subunit 5 (Ints5) in zebrafish embryos causes aberrant splicing of smad1 and smad5 
RNA, and reduced expression of the hematopoietic genes, stem cell leukemia (scl) and 
gata1. Blood smears from ints5 morphant embryos show arrested red blood cell 
differentiation, similar to scl-deficient embryos.  Interestingly, targeting other Integrator 
subunits also leads to defects in smad5 RNA splicing and arrested hematopoiesis, 
suggesting that the Int proteins function as a complex to regulate the BMP pathway 
during hematopoiesis.  Our work establishes a link between the RNA processing 
machinery and the downstream effectors of BMP signaling, and reveals a new group of 
proteins that regulate the switch from primitive hematopoietic stem cell identity and 
blood cell differentiation by modulating Smad function. 
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1.1 THE INTEGRATOR COMPLEX 
1.1.1 Discovery Of The Integrator Complex 
A subunit of the Integrator complex (Integrator subunit 5, Ints5) was recently identified 
from a genetic screen for genes that function in Drosophila oogenesis. Depletion of ints5 
in the Drosophila germarium causes failure in production of mature oocytes (Cai et al., 
unpublished data). Identification and characterization of the fly mutant showed that the 
gene encoded a component of the Integrator complex. The Integrator complex was 
originally discovered in human embryonic kidney (HEK) 293 cells by the Shiekhattar 
group (Baillat et al., 2005). They were interested in the function of Deleted in split 
hand/split foot 1 (DSS1), the product of a candidate gene for split hand/split foot. DSS1 
was initially identified as a small acidic protein that could directly interact with the C-
terminal domain (CTD) of the BRCA2 protein (Marston et al., 1999). To elucidate the 
molecular mechanism by which DSS1 induces its functional effects, Baillat et al isolated 
the DSS1-containing complexes from HEK293-derived cell lines stably expressing Flag-
DSS1 and identified its components by mass spectrometry. They showed that DSS1 is a 
component of multiple, distinct complexes. They identified the 19S proteasome subunits 
as the main component of DSS1-associated polypeptides. In addition, they obtained 
peptide sequences corresponding to BRCA2, RNA polymerase II (RNAPII), and a 
number of uncharacterized human open reading frames, which included the novel 
subunits of a large complex that they named as Integrator (for integrating the CTD of 
RNAPII largest subunit with the 3’ end processing of small nuclear RNAs, snRNA, U1 
and U2) (Baillat et al., 2005). 
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The Integrator subunits (Ints) were found to stably associate with RNAPII. Analysis of 
Ints6, Ints7, and Ints12 protein sequences and structures revealed the presence of a von 
Willebrand factor type A (vWA) domain, an ARM repeat, and a PHD domain, 
respectively (Baillat et al., 2005). More interestingly, Ints11 and Ints9 display sequence 
homology to the subunits of the cleavage and polyadenylation specificity factor CPSF-73 
and CPSF-100, respectively (Dominski et al., 2005). Importantly, Ints11 contains the 
putative catalytic β-lactamase domain, so it is predicted to function as an RNA-specific 
endonuclease (Callebaut et al., 2002). Although the Integrator subunits do not display any 
homology to yeast genes, nearly all of them have homologues in metazoans.  
1.1.2 The Integrator Complex Is Recruited To The U1 And U2 snRNA Genes 
And Mediates RNA Polymerase II Dependent snRNA Transcription.  
Baillat et al. showed that although the Integrator complex directly bound to the CTD of 
RNAPII, neither ectopic expression nor depletion of Integrator subunits using small 
interfering RNA (siRNA) transfection resulted in alteration of mRNA expression level. 
Moreover, they could not detect the Integrator complex at the promoters of protein 
coding genes, using chromatin immunoprecipitation (ChIP). This led them to examine 
other genes (besides protein coding genes), whose expression is also mediated by 
RNAPII (Baillat et al., 2005).  
It is known that the CTD of RNAPII is also required for the transcription and processing 
of U1 and U2 snRNAs (Uguen and Murphy, 2003). Therefore, they examined the 
promoter and coding region of U1 and U2 genes for the presence of the Integrator 
complex and RNAPII using ChIP. The ChIP experiments demonstrated that the 
Integrator-RNAPII complex specifically recruited to U1 and U2 snRNA genes. 
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Furthermore, Ints11 associates with RNAPII and other subunits of the Integrator complex 
and also specifically binds to both the promoter and 3’ end of U1, U2 snRNA genes. 
(Baillat et al., 2005).   
snRNAs are core components of the spliceosome, a complex assembly of 
ribonucleoparticles involved in pre-mRNA processing (Jurica and Moore, 2003). The 
majority of snRNAs are transcribed by RNAPII to yield short nonpolyadenylated 3’ 
extended precursors (Wieben et al., 1985). These precursors are then exported to the 
cytoplasm for further 3’ trimming and incorporated into the small nuclear 
ribonucleoparticles (snRNPs). The formation of proper snRNA precursors depends on the 
3’ box, located 9–19 nucleotides downstream of the 3’ end of the mature snRNA and the 
presence of a snRNA-compatible promoter at the 5’ end of the gene (Egloff et al., 2008; 
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Figure 1.1 The structure of human U1, U2 snRNA genes transcribed by pol II. 
The diagram shows the DSE and PSE cis-acting promoter elements and the RNA-
processing element, 3’box. Their position relative to the transcription start site is noted. 
The start site of transcription is marked with an arrow above the line and the extent of the 
transcription unit of the U1 and U2 genes is indicated below the line by an arrow. 









































Chapter I                                              Introduction 7 
1.1.3 The Integrator Complex Mediates the 3’ End Processing of U1 And U2 
snRNAs  
Analysis of U1 and U2 primary transcripts after the deletion of Ints1 (the largest subunit 
of the Integrator complex) and Ints11 (the subunit with predicted catalytic activity) 
revealed a pronounced accumulation of primary transcripts, consistent with a defect in 
processing the 3’ end of U1 and U2 snRNA transcripts (Baillat et al., 2005). This 
accumulation represents a failure to cleave the primary transcript at its natural processing 
site located upstream of the 3’ box (Wieben et al., 1985). However, the defect in 3’end 
processing did not result in decreased levels of mature U1 and U2 transcripts, possibley 
because RNAPII-transcribed spliceosomal snRNAs (U1, U2, U4, and U5) have long half-
lives, exceeding 60 hours (Baillat et al., 2005; Fury and Zieve, 1996) (Figure 1.2). 
1.1.4 Function Of The Integrator Subunits 
As the Integrator complex plays a vital role in transcription and processing of snRNA, 
dysfunction of the Integrator subunits can lead to various developmental defects. In fact, 
recent work has shown that disruption of the murine Integrator subunit 1 causes growth 
arrest and eventual apoptosis at early blastocyst stages (Hata and Nakayama, 2007).  
Integrator subunit 3 may be involved in the development and/or progression of 
hepatocellular carcinoma (HCC) tumors (Inagaki et al., 2008). More intriguingly, 
integrator subunit 5 (Ints5) has been recently identified with an important function in 
Drosophila oogenesis. It is found that depletion of ints5 in Drosophila germarium affects 
Decapentaplegic (Dpp, the homologue of bone morphogenetic protein, BMP) signaling 
activities, which in turn leads to maturation defects in oocytes (Cai et al., unpublished 
data). Therefore, it is possible that Ints5 or Integrator complex are required for proper  
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Figure 1.2 The Integrator complex plays important role in 3’Box-dependent 
processing of snRNA. 
(1) The Integrator complex interacts with RNA polymerase II (Pol II) at the promoter of 
snRNAs genes. Various transcription activators (grey) are involved in recognizing the 
promoter of snRNA gene and recruitment of Pol II to initiate snRNA transcription. (2) 
The Integrator complex travels with Pol II till the 3’ box is transcribed. (3) Cleavage 
occurs at the upstream of the 3’ box after the Integrator complex binds to the exposed 
3’box. (4) Termination occurs after release of the Integrator complex and the cleaved 
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BMP function during vertebrate development as well. Here, I am interested in studying 
the function of Integrator subunits, especially Ints5, and in elucidating the link between 
Ints5 and BMP signaling during early development of zebrafish. The study presented in 
this thesis shows that the Integrator complex functions in zebrafish hematopoiesis to 
regulate the switch from primitive hematopoietic stem cell identity and blood cell 
differentiation by modulating BMP/Smad signaling. This work may provide insights into 
the mechanism by which the Integrator complex and individual subunits may function in 
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1.2 BMP SIGNALING  
Since Ints5 affects Dpp (the homologue of bone morphogenetic protein, BMP) signaling 
in the Drosophila germarium (Cai et al., unpublished data), it is possible that Ints5 and 
the Integrator complex are also required for proper BMP function during vertebrate 
development. 
Bone morphogenetic proteins (BMPs) form a large subgroup within the transforming 
growth factor-β (TGF-β) superfamily, which is a group of secreted peptide growth factors 
in metazoans comprising the TGF-βs, Activins/Inhibin/Nodal and related proteins (Serra, 
2002).The activity of BMPs was first identified in the 1960s, but the proteins responsible 
for bone induction remained unknown until the purification and sequence of bovine 
BMP-3 (osteogenin) and cloning of human BMP-2 and 4 in the late 1980s (Wozney et 
al., 1988). To date, about 20 BMP family members have been identified and 
characterized, and can be subdivided into several groups based on their structures and 
functions. BMP-2, BMP-4, and the Drosophila Dpp are classified as BMP-2/4 group. 
BMP-5, BMP-6, BMP-7 (also termed osteogenic protein-1, OP-1), BMP-8 (OP-2), and 
the Drosophila gbb-60A gene product form the BMP-5 subgroup (also known as OP-1 
group). Growth-differentiation factor-5 (GDF-5, also termed cartilage-derived 
morphogenetic protein-1, CDMP-1), GDF-6 (CDMP-2 or BMP-13), and GDF-7 (BMP-
12) form the third group. Members of the BMP family have distinct expression profiles 
and the biological activities are not identical among members. One of the reasons is that 
they bind to BMP receptors with different affinities (Miyazono et al., 2005; Serra, 2002). 
The current model of induction of signaling responses by BMP factors is a linear pathway 
from the type II and type I receptor kinases to Smad activation, resulting in ligand-
Chapter I                                              Introduction 12 
stimulated transcriptional activation or repression (Figure 1.3). The SMADs are critical 
for TGF-β/BMP family signaling (Derynck and Zhang, 2003; Kitisin et al., 2007). 
However, more recent data also suggests that SMAD-independent pathways exist. For 
instance, TGF-β rapidly activates Rho family guanosine triphophatases (GTPases) and 
mitogen-activated protein kinases (MAPKs) through their upstream kinase activators 
such as TAK1 (TGF-β activated kinase 1) and protein kinase B (PKB, also called Akt). 
However, no clear link between these pathways to receptors has been identified, and this 
area remains to be investigated (Attisano and Wrana, 2002; Derynck and Zhang, 2003; 
Zhang, 2009).  
In addition, the proper functioning of BMP signaling also depends on its constitutive and 
extensive communication with other signaling pathways, such as TGF-β, MAPK, 
PI3/Akt, Wnt, Hedgehog, Notch, and the interleukin/interferon-gamma/tumor necrosis 
factor-alpha cytokines induced signaling pathways. This interplay between TGF-β/BMP 
and other pathways is context dependent and tightly regulated both spatially and 
temporally, leading to the remarkable complexity and diversity of BMP functions and 
eventually desirable biological outcomes (Guo and Wang, 2009; Miyazono et al., 2005; 
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Figure 1.3 BMP signaling pathway. 
BMP signaling is transduced through Smad proteins. BMP homodimer or heterodimer 
ligand binds to type II receptor, whose kinase activity is constitutively active. Ligand 
binding induces the association of type I and type II receptors, which leads to a 
unidirectional phosphorylation event in which the type II receptor phosphorylates the 
type I receptor, thereby activating its intracellular kinase domain and induce 
phosphorylation of R-Smads. R-Smads form complexes with Co-Smad, and move into 
the nucleus, where they regulate transcription of target genes. One of the targets of Smad 
signaling is I-Smads, which suppress Smad signaling by interacting with activated 
receptors and inhibiting the complex formation between R-Smads and Co-Smad. E3 
ubiquitin ligase Smurf1/2 target poly-ubiquitination and proteasomal degradation of R-
Smad and the activated receptor complex. BMP activity is also negatively regulated by 
extracelullar antagonists, such as Chordin, Noggin, Follistatin, and Cerberus. Another 
level of regulation of this pathway is achieved through the proteolytic activity of the 
metalloprotease-Tolloid, which cleaves BMP antagonist, such as Chordin and in turn 
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1.2.1 BMP/Smad Signaling Pathway (Figure 1.3) 
Parallel work in files, worms and vertebrates has revealed a conserved BMP signaling 
pathway (Attisano and Wrana, 2002; Roberts and Derynck, 2001). The cell-surface 
receptor that carries the BMP signal into the cell is a complex of single-pass 
transmembrane serine and threonine kinases. This receptor complex consists of two 
distinct proteins, known as the type I and type II receptors. The BMP ligand binds to type 
II receptor, whose kinase activity is constitutively active. Ligand binding induces the 
association of type I and type II receptors, which leads to a unidirectional 
phosphorylation event in which the type II receptor phosphorylates the type I receptor, 
thereby activating its intracellular kinase domain (Attisano and Wrana, 2002).  
The activated type I receptor then signals to the SMAD family of intracellular mediators. 
Vertebrate SMADs can be divided into three functional classes: (1) receptor-activated 
SMADs (R-Smads), (2) co-mediator SMAD 4 (Co-Smads), and (3) inhibitory SMADs 6 
and 7 (I-Smads). The type I receptors are critical to determine the specificity of the 
downstream SMAD. BMP type I receptors specifically phosphorylate R-Smads: Smad 1, 
5, and 8. In contrast, TGF-β/Activins/Nodal signaling pathway function through R-
Smads: Smad2 and 3 (Attisano and Wrana, 2002; Jurica and Moore, 2003; Miyazono et 
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Figure 1.4 The classification and schematic representation of Smad family members. 
There are three classes of Smad proteins. R-Smads contain an SSXS motif at the C-
terminus, where the last two Ser residues are phosphorylated by the type I receptor. Both 
R-Smads and Co-Smads have highly conserved MH1 domains (red) and MH2 domains 
(blue). MH1 and MH2 domains are separated by linker region with various lengths 
(green). I-Smads shows limited homology with R-Smads and Co-Smads, and this 
homology is restricted to the MH2 domain. PY motif is found in both R-Smad and I-
Smad. L3 loop and α-helix 1 (H1) in MH2 domain of R-Smad are required for the 
interaction between R-Smad and type I receptor. (Reviewed by Nakayama et al., 2000 
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The receptor regulated SMADs (R-Smads), are directly phosphorylated by the type I 
receptors on two conserved serines at the COOH-terminus. Phosphorylation of R-Smads 
induces release from the receptor complex as well as from cytoplasmic anchor proteins, 
including SARA (SMAD anchor for receptor activation) and cytoplasmic PML 
(promyelocytic leukemia protein) (Figure 1.5). Phosphorylation also stimulates R-Smads 
to interact with Co-Smads, Smad4 and accumulate together in the nucleus as heteromeric 
complexes. In the nucleus, the Smads associate with various DNA binding partners and 
transcriptional coactivators or corepressors to positively or negatively regulate target 
gene expression (Attisano and Wrana, 2002; Heldin et al., 1997; Massague et al., 2000).  
I-SMADs (Smad6 and 7), counteract the effects of R-Smads and thus negatively regulate 
BMP signaling (Moustakas et al., 2001; Wrana, 2000). BMP signaling is also opposed 
extracellularly by antagonists originated from the organizer, including Chordin, Noggin, 
Follistatin, and Cerberus, all of which are able to bind BMPs and block activation of their 
receptors (Iemura et al., 1998; Piccolo et al., 1999; Piccolo et al., 1996; Zimmerman et 
al., 1996). Another level of regulation of this pathway is achieved through the proteolytic 
activity of the metalloprotease-Tolloid, which cleaves BMP antagonist, such as Chordin 
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Figure 1.5 Turnover of BMP receptors. 
Internalization of the receptor complex can occur via two pathways: (i) the clathrin- and 
(ii) lipid raft-caveolae endocytic routes. Early endosomes bind SARA, which can, 
together with cytoplamic PML (cPML), recruit R-Smads, Smad 1,5, 8 to the activated 
receptor. R-Smads are phosphorylated by the type I receptor, and in turn can form 
heteromeric complexes with the Co-Smad, Smad4.These activated Smad complexes 
accumulate in the nucleus, where they directly or indirectly bind to specific promoter 
region on target genes together with transcription factor and/or co-activators/repressors. 
On the other hand, receptor complexes that are endocytosed into lipid rafts-caveolae 
microdomains are predestined to be degraded. I-Smads (Smad6 and Smad7) can recruit 
E3 ubiquitin ligase Smurf1/2 that target poly-ubiquitination and proteasomal degradation 
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1.2.1.1 BMP Ligands 
BMP ligands are synthesized as inactive precursors that become activated after 
proteolytic cleavage. The cleavage occurs after the multi-basic amino acid motifs -Arg-
Ser-Lys-Arg- to generate C-terminal mature proteins before they are secreted as 
homidimers or heterodimers (Aono et al., 1995; Cui et al., 1998; Nishimatsu and 
Thomsen, 1998). This processing event has been proposed to regulate the diffusion of 
BMPs, thereby controlling the range over which these molecules can signal during 
embryonic development (Cui et al., 2001). Members of a family of higher eukaryotic 
endoproteases, named proprotein convertases (PCs), are good candidates for endogenous 
BMP convertases. In mammals, seven members of this family have been characterized 
and designated as Furin, PC2, PC3, PACE-4, PC4, PC5/PC6A and B, and LPC/PC7/ PC8 
(Steiner, 1998). Individual PCs exhibit overlapping, but distinct, substrate specificities 
(Breslin et al., 1993; Creemers et al., 1993). Furin, the first characterized member of PC 
family, is a membrane-localized, calcium-dependent serine endoprotease that cleaves 
proprotein molecules following the consensus sequence Arg- X-X-Arg (Molloy et al., 
1992). Many precursor proteins, including those for TGF-βs share this cleavage site and 
can be efficiently cleaved by Furin in vivo and in vitro (Bresnahan et al., 1990; Dubois et 
al., 1995; Nakayama, 1997). 
1.2.1.2 Receptors Of BMP Signaling Pathway 
Members of the BMP family bind to two distinct serine/threonine kinase type I and type 
II receptors. The constitutively activated type II receptors phosphorylate Gly-Ser (GS) 
domains of the type I receptors upon ligand binding, leading to the activation of type I 
receptor kinases (Heldin et al., 1997; Miyazono et al., 2005; Shi and Massague, 2003).  
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Then, the specificity of downstream intracellular signals is mainly dependent on type I 
receptors. Of the four type I receptors for BMPs, BMP-2/4 preferentially bind to ALK-3 
and ALK-6, whereas members of the BMP-5 group bind to ALK-2 and ALK-6. In 
contrast, those of the GDF-5 group bind to ALK-6, but not efficiently to other receptors 
(Derynck and Zhang, 2003). In addition to the members of the BMP family, mullerian 
inhibiting substance (MIS) has been shown to bind to ALK-2 in the presence of MIS type 
II receptor, and to mediate BMP-like signaling in target cells (Clarke et al., 2001; Visser 
et al., 2001). Mutations in the ALK-3 gene have been found in some patients with 
juvenile polyposis (Howe et al., 2001). 
There are three different type II receptors, BMPR-II, ActR-II, and ActR-IIB (Derynck 
and Zhang, 2003). BMPR-II has a long C-terminal tail following the serine/ threonine 
kinase domain. Hassel et al. reported the proteomics analyses of BMPR-II interacting 
proteins, and found that several cytoskeletal components interact with the C-terminal tail 
as well as the kinase domain of BMPR-II (Hassel et al., 2004). Thus, the C-terminal tail 
of BMPR-II may play important roles in the regulation of cytoskeletal protein functions. 
In fact, truncations of BMPR-II in the C-terminal tail have been found in some patients 
with familial primary pulmonary hypertension (PPH) (Deng et al., 2000; Lane et al., 
2000).  
Besides, the turnover of receptor complex is important for the regulation and termination 
of signaling events. After type I receptor activation, receptor internalization can occur via 
two pathways: the clathrin-endocytic and lipid raft-caveolae endocytic routes (Figure 
1.5). Clathrin coated internalization guides receptor complex to early endosomes that are 
enriched for phosphatidylinositol 3-phosphate. Early endosomes bind FYVE domain 
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protein SARA, which can, together with PML, recruit R-Smads to the activated receptor. 
R-Smads are then phosphorylated by type I receptor, and participate in downstream 
signaling. The receptors can travel back to the cell surface. In contrast, receptor 
complexes that are endocytosed into lipid rafts-caveolae vesicles are lead to be degraded. 
I-Smads bind to activated receptors in the coveolae, and serve as adapters to recruit E3 
ubiquitin ligase, Smurfs for poly-ubiquitination and proteasomal degradation of TGF-β 
receptor complex (Itoh and ten Dijke, 2007).  
1.2.1.3 Smads Of BMP Signaling Pathway  
R-Smads and Co-Smads have highly similar amino-acid sequences at their N- and C-
termini, which are termed as Mad homology (MH)1 and MH2 domains, respectively. The 
two domains are separated by a divergent proline-rich linker region with variable lengths. 
The MH1 domain of R-Smads and Co-Smads can bind to the specific DNA sequences 
and also repress the function of MH2 domain. In contrast, the MH2 domain plays 
important roles in protein interactions. For example, MH2 domain of R-Smads directly 
binds to type I receptors, forms oligomer with Co-Smads, and interacts with coactivators 
for transcriptional activation. In addition, only R-Smads have a Ser-Ser-X-Ser (SSXS) 
motif at their COOH-terminal ends, serving as the phosphorylation site by type I 
receptors (Massague et al., 2005; Miyazono et al., 2005) (Figure 1.4). 
The L45 loop within the type I receptor kinase domain and the L3 loop in the MH2 
domains of R-Smads determine the specificity of intracellular signaling induced by TGF-
βs. BMP-Smads, Smad1, 5 and 8 are phosphorylated by BMP type I receptors (ALK-1, 
ALK-2, ALK-3 and ALK-6), whereas TGF-β/Activin-Smads, Smad2 and 3 are activated 
by TGF-β and activin type I receptors (ALK-4 and ALK-5) and orphan type I receptor 
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ALK-7.  For the interaction of Smad1 with AlK-1 and ALK-2, not only its L3 loop, but 
also the α-helix 1 (H1) in MH2 domain is required (Chen and Massague, 1999; Itoh and 
ten Dijke, 2007; Miyazono et al., 2005) (Figure 1.4).  
The Co-Smad, Smad4 can form heteromeric complexe with all activated R-Smads and is 
thus a shared component in TGF-β, activin and BMP signal transduction. Work by 
Kawabata et al, together with the finding that MH2 domain of Smad4 forms a trimer in 
solution, suggests that the hetero-oligomers may be heterotrimers, composed of two R-
Smads and one Smad4, or one R-Smad and two Smad4 (Kawabata et al., 1998; Shi et al., 
1997). Although phosphorylated R-Smads can form oligomers and translocate into the 
nucleus even in the absence of Co-Smad, Co-Smad stabilizes the structures of the Smad 
oligomers. Therefore, Co-Smads guarantee the efficient transcriptional activity of the 
Smad complexes (Shi and Massague, 2003).  
I-Smads, Smad6 and Smad7, are distantly related members of the Smad family. 
Expression of I-Smads is induced by ligand stimulation. For example, Drosophila 
homologue of Smad6/7, Daughters against Dpp (Dad), is induced by Dpp (Drosophila 
homologue of Bmp2/4) signal. This finding indicates that I-Smads regulate TGF-β/BMP 
signaling by a negative feedback loop (Christian and Nakayama, 1999; Miyazono et al., 
2005; Tsuneizumi et al., 1997). I-Smads contain a conserved MH2 domain that interacts 
with type I receptors to compete with R-Smads for receptor binding. It is also shown that 
Smad6 binds to activated Smad1, and prevents complex formation between Smad1 and 
Smad4 (Hata et al., 1998; Heldin et al., 1997; Murakami et al., 2003). Both Smad6 and 
Smad7 inhibit BMP signaling, while Smad7 is more potent in inhibiting TGF-β/activin 
signals than Smad6.The N-terminal regions of I-Smads show a weak similarity to MH1 
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domains of R- and Co-Smads, and may have a role in determining signal specificity 
(Miyazono et al., 2005). 
The linker region of R-Smads has consensus sequences phosphorylated by MAPK. 
MAPK phosphorylation inhibits R-Smads nuclear localization, thereby antagonizing 
TGF-β signaling (Kretzschmar et al., 1997). In Xenopus embryos, MAPK induced 
phosphorylation of Smad1 linker region by IGF and FGF (fibroblast growth factor) plays 
an important role in neural induction (Pera et al., 2003). Although mice with mutations in 
the linker region of Smad1 (Smad1L/L) exhibit less severe phenotypes compared to 
Smad1-null mice or those with a mutation in the C-terminus of Smad1, Smad1L/L mice 
exhibit defects in gastric epithelial homeostasis and formation of primordial germ cells, 
suggesting the functional importance of MAPK-mediated Smad1 phosphorylation in vivo 
(Aubin et al., 2004). In addition, the PPXY sequence (also called PY motif), which 
interacts with WW domain containing proteins, such as E3 ligase-Smurf, is present in the 
linker regions of most R- and I-Smads (Ebisawa et al., 2001; Kavsak et al., 2000) (Figure 
1.4). 
1.2.1.4 Regulation of R-Smads  
Ubiquitin–proteasome-mediated degradation controls the levels of R-Smads post-
translationally. R-SMAD protein is regulated by the ubiquitin proteasome pathway 
through association with E3 ubiquitin ligases such as Smurf1 and Smurf2. Smurf proteins 
are members of the HECT domain containing E3 ubiquitin ligases. The WW domains of 
Smurfs bind to the PY motifs of R-SMADs. Smurf1 interacts with Smad1 and Smad5, 
thereby affecting BMP responses, whereas Smurf2 interacts more broadly with different 
R-Smads, allowing interference with BMP and TGF-β/activin signaling. Nevertheless, 
Chapter I                                              Introduction 26 
Xenopus embryo assays indicate that Smurf1 and Smurf2 primarily target the BMP 
pathway (Derynck and Zhang, 2003; Miyazono et al., 2005). 
Recent work has revealed that the Smads are also post-transcriptionally regulated.  Jiang 
et al. identified a ubiquitously expressed novel isoform, SMAD5β, encodes a 351 amino 
acid protein with a truncated MH2 domain and a unique C-terminal tail of 18 amino 
acids. The expression level of the smad5β isoform is higher in CD34+ hematopoietic 
stem cells than in terminally differentiated peripheral blood leukocytes, thereby 
implicating the function of β form in hematopoietic stem cell homeostasis (Jiang et al., 
2000).  It is also indicated that the alternative splicing of smad5 is differentially regulated 
during maturation of hematopoietic cells. Therefore, the post-transcriptional processing 
of Smads is important for their function. However, the mechanisms of this process are 
poorly understood. 
The elucidation of BMP signal transduction pathways might provide insights into human 
diseases. Various human syndromes and illnesses, both hereditary and spontaneous, have 
been attributed to mutations in BMP pathway components. Especially, mutations in 
SMADs have been associated with cancers and anemia (de Caestecker et al., 2000; 
Massague et al., 2000).  
 
1.2.2 Function Of BMP Signaling In Dorso-ventral Patterning 
The activities of BMPs are achieved by regulating proliferation, differentiation, migration 
and apoptosis of different cell types. Studies from transgenic and knock-out mice and 
from other animals and humans with naturally occurring mutations in BMPs and related 
genes have shown that BMP signaling plays multiple roles at different developmental 
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stages (Abe, 2006; Dale and Jones, 1999; de Caestecker et al., 2000; Guo and Wang, 
2009; Larsson and Karlsson, 2005; Maxson and Ishii, 2008; Miyazono et al., 2005; 
Nakayama et al., 2000). Here I mainly introduce the function of BMP signaling in 
patterning the dorso-ventral axis of vertebrate embryos. 
One of the earliest and best documented roles for BMPs is in patterning the dorso-ventral 
axis (Graff, 1997) (Figure 1.6). In vertebrate, maternally deposited determines leads to 
the establishment of dorsal organizer. One of the essential organizer factors is nodal 
related protein. Nodal also belongs to TGF-β superfamily and occurs in deuterostoms and 
serves as mesoderm and endoderm inducers. During gastrulation, the organizer induces 
dorsal fates within mesoderm, anterior fates within endoderm, and neural fates within 
ectoderm. The organizer seems to cause these events primarily by opposing 
morphogenetic activities from the ventro–lateral regions of the embryo (De Robertis et 
al., 2000). Intriguingly, Studies in Xenopus have revealed the existence of BMP signaling 
pathway, which specifies the ventral and lateral fate of the embryo, together with Wnt 
pathways (Harland and Gerhart, 1997).The role of BMP signaling in dorso–ventral 
patterning of the gastrula embryo is highly conserved during evolution form Drosophila 
to vertebrates although dorso-ventral axis in Drosophila is inverted relative to that of 
vertebrate (De Robertis et al., 2001; Holley and Ferguson, 1997; Holley et al., 1995; 
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Figure 1.6 The dorsoventral polarity in zebrafish and Drosophila. 
Dorsal–ventral polarity in arthropods has been inverted with respect to that of vertebrates 
in the course of evolution. In zebrafish, maternally deposited factors determine the 
establishment of dorsal organizer. During gastrulation, the organizer induces dorsal fates 
by opposing BMP activities from the ventral–lateral regions of the embryo. The graded 
BMP activity confers positional values along the dorsoventral axis for both mesoderm 
and ectoderm. This morphogenetic activity of BMPs could be established via an 
inhibitory gradient set up by secreted BMP antagonists from the dorsal organizer, such as 
Cerebrus, Chordin, Follistatin and Noggin. In Drosophila, BMP/DPP signaling induces 
formation of the dorsal ectoderm and amnioserosa, an extra-embryonic membrane that 
has the dorsal-most fate in the fly embryo. In contrast, the ventral ectoderm fate, 
neurogenic ectoderm, requires the absence of DPP signaling. Similarly, DPP activity is 
negatively regulated by the fly homologue of Chordin, Sog. (Adapted from De Robertis 
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Early in Drosophila development, cells acquire distinct fates along the dorso–ventral axis. 
In syncytial blastoderm, graded levels of nuclear Dorsal (DL) sub-divide the embryo into 
mesoderm and ectoderm. The DL gradient sets the stage for further patterning of the 
ectoderm by BMP signaling. Normal dorso–ventral patterning requires two BMP ligands, 
Decapentaplegic (DPP), a BMP2/4 homologue and Screw, a BMP7 homologue. They 
induce formation of the dorsal ectoderm and amnioserosa, an extra-embryonic membrane 
that has the dorsal-most fate in the fly embryo. In contrast, the ventral ectoderm fate, 
neurogenic ectoderm, requires the absence of DPP signaling (Raftery and Sutherland, 
2003) (Figure 1.6). Intriguing, in Drosophila, Screw and another BMP family member 
Gbb-60A, have been shown to synergize with Dpp to regulate growth and patterning in 
wing imaginal discs (Chen and Struhl, 1998; Haerry et al., 1998; Khalsa et al., 1998; 
Neul and Ferguson, 1998; Nguyen et al., 1998). It is possible that the BMP ligand 
heterodimers are important for dorso-ventral patterning as well. 
In Xenopus, expression of BMP-4 is restricted to cells on the ventral side of gastrula 
stage embryos, where it plays a central role in specifying ventral mesodermal and 
ectodermal fates. When BMP-4 is mis-expressed in the organizer, the cells in the dorsal 
side differentiate into blood rather than notochord and muscle, or into epidermis rather 
than neural tissues. Conversely, when endogenous BMP signaling is blocked by 
introducing dominant negative forms of BMP ligands or receptors, blood fate is 
eliminated in ventral cells and they become muscle instead. Furthermore, blocking BMP 
signaling pathway in the animal caps of embryos (ectoderm explants) causes these cells 
to differentiate into neural tissues. Thus, BMP-4 is required for ventral mesoderm 
formation and for the induction of epidermal fate at the expense of neural tissues (Dale 
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and Jones, 1999; Fainsod et al., 1994).  
It has been proposed that graded BMP activity confers positional values along the dorso-
ventral axis for both mesoderm and ectoderm (Figure 1.6). This morphogenetic activity 
of BMPs could be established via an inhibitory gradient set up by secreted BMP 
antagonists from the dorsal organizer, such as Cerebrus, Chordin, Follistatin and Noggin 
(Dale and Wardle, 1999; De Robertis et al., 2001). Thus, according to current model, 
high BMP activity or low BMP antagonism induces blood in mesoderm and epidermis in 
ectoderm, intermediate BMP activity or intermediate BMP antagonism induces lateral 
plate mesoderm (heart, kidney) and neural crest in ectoderm, and low BMP activity or 
high BMP antagonism induces somites and notochord in mesoderm and neural plate in 
ectoderm (Dale and Wardle, 1999). 
This morphogen model is further confirmed by phenotypic analyses of zebrafish mutants. 
Dorsalized mutants swirl (swr, bmp2b), snailhouse (snh, bmp7), somitabun (sbn, smad5), 
piggytail (pgy, smad5), mini-fin (mfn, tolloid) and lost-a-fin (laf, alk8) exhibit expansion 
of dorso-lateral mesoderm at the expense of ventral mesodermal derivatives, as well as 
expansion of presumptive neural tissue at the expense of epidermal precursors (Bauer et 
al., 2001; Connors et al., 1999; Kishimoto et al., 1997; Mullins et al., 1996). Conversely, 
the ventralized mutant chordino (din, chordin), mercedes (mes, sizzled), and ogon (ogo, 
sizzled) shows reduction of dorsal derivatives such as somitic mesoderm and 
neurectoderm, together with expansion of ventral mesoderm and epidermis 
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1.3 HEMATOLOGY IN ZEBRAFISH 
When I studied the function of Ints5, I found that knocking-down Ints5 causes a lack of 
blood circulation, reduced expression of hematopoietic genes and arrested red blood cell 
differentiation in early zebrafish embryos. Therefore, here, I mainly studied the role of 
Integrator subunits in hematopoiesis, using zebrafish as a model system.  
1.3.1 Zebrafish As A Model For Hematopoiesis 
Zebrafish is an ideal organism to analyze the molecular mechanisms underlying 
developmental hematopoiesis. Fish represents the largest group of vertebrates, with more 
than 20,000 known species. Fish embryos are often externally fertilized and are optically 
transparent, allowing observation of blood cell formation, differentiation and migration. 
Usually, the circulation of blood cells can be observed from 24 hours post-fertilization in 
zebrafish and embryos can survive for several days without any circulating blood cells. 
One can screen for hematopoietic defects at different developmental stages by simple 
observation under a dissecting microscope.  Besides, the generation time of zebrafish is 
short, females typically lay up to hundreds of eggs per crossing and adults are small and 
easy to maintain (Shafizadeh and Paw, 2004; Westerfield, 2000). 
Recently, modern reverse genetic techniques have been used for zebrafish hematology 
research, including transient gene over-expression and knockdown (eg. anti-sense 
morpholinos, RNAi), stable transgenesis, and recovering stable mutated alleles by 
TILLING (Targeting Induced Local Lesions In Genomes) or from catalogued libraries of 
insertional mutant lines (Carradice and Lieschke, 2008). Furthermore, a number of 
hematopoietic molecular markers have been characterized, also several groups have 
completed large-scale forward genetic screens for chemically induced mutations, from 
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which, many mutants with defects in the embryonic hematopoiesis have been identified 
(Driever et al., 1996; Haffter et al., 1996). In addition, cell biology techniques, such as 
flow cytometry and transplantation, are also available for in vivo functional studies of 
specific cell types. So far, a dramatic progress in hematopoiesis study has been made in 
zebrafish. It is obvious that zebrfish has already become a popular organism for studying 
the hematopoiesis (Berman et al., 2005; Shafizadeh and Paw, 2004; Traver, 2004). 
1.3.2 Zebrafish Primitive Hematopoiesis 
All vertebrate have two waves of hematopoieis. The earlier one is known as primitive or 
embryonic hematopoietic wave and predominantly produces erythrocytes and primitive 
macrophages but not lymphoid cells. In mammals and birds, the first hematopoietic wave 
originates from the extraembryonic tissue-yolk sac (Galloway and Zon, 2003; Zon, 
1995). In zebrafish, primitive hematopoiesis occurs at two mesodermal sites, the 
intermediate cell mass (ICM) located in the trunk ventral to the notochord, developing 
from the ventral lateral plate mesoderm (LPM), and the rostral blood island (RBI) arising 
from the cephalic/anterior LPM (Carradice and Lieschke, 2008; de Jong and Zon, 2005) 
(Figure 1.7). In zebrafish and Xenopus, dorso-ventral patterning depends on the presence 
of transforming growth factor β (TGF-β) superfamily members, especially nodal related 
proteins and a gradient of bone morphogenetic proteins (BMPs) (De Robertis et al., 2000; 
He and Chen, 2005). Establishment of the ventral mesoderm eventually leads to 
formation of hemangioblast progenitors (common progenitors for both hematopoietic and 
endothelial lineages), marked by the co-expression of transcription factor genes stem cell 
leukemia (scl), lmo2 and gata2 in both the ICM and RBI from 2-somite stage (Davidson 
and Zon, 2004). Cells in the ICM (analogous to mammalian yolk sac blood island) 
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differentiate into the endothelia cells of the trunk vasculature and proerythroblasts, which 
enter the circulation at around 24 hpf, whereas cells in the RBI generate endothelia cells 
and macrophages (de Jong and Zon, 2005; Larsson and Karlsson, 2005). 
1.3.3 Zebrafish Definitive Hematopoiesis 
The second hematopoietic wave is known as definitive or adult hematopoiesis, and 
produces all the blood lineages. Zebrafish definitive hematopoiesis starts at 48 hpf in the 
ventral wall of the dorsal aorta, equivalent to the aorta-gonad-mesonephros (AGM) in 
mammals. Mammalian hematopoiesis later transitions from the AGM to the fetal liver 
and bone marrow (Galloway and Zon, 2003; Zon, 1995) (Figure 1.7). In zebrafish, 
definitive hematopoiesis is initiated by Hedgehog, vascular endothelial growth factors 
(Vegfs), and Notch signalings (Gering and Patient, 2005). At 31 hpf, c-myb and runx1 
start to express in the dorsal aorta, predicting the formation of the definitive 
hematopoietic stem cells (HSCs), which can give rise to all different types of blood cells 
(Burns et al., 2002; Kalev-Zylinska et al., 2002; Mucenski et al., 1991). Subsequently, 
HSCs are colonized in the kidney, thymus and pancreas. The kidney becomes the primary 
hematopoietic organ from the larval stage and throughout the lifespan of zebrafish 
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Figure 1.7 Approximate duration and location of hematopoietic activity in different 
tissues during zebrsfish embryogenesis. (Modified from Davidson and Zon, 2004 and 











































Chapter I                                              Introduction 37 
1.3.4 Transcriptional Regulation Of Primitive Hematopoiesis  
In zebrafish, hemangioblasts originate from the ventral margin of the embryo (Vogeli et 
al., 2006). Similarly, in mouse, the hemangioblast progenitors arise from a mesodermal 
population of cells positive for Brachyury (T) expression (Fehling et al., 2003). Although 
it is not very clear how the ventral mesodermal cells are specified into hemangioblasts, 
BMPs, FGF and Wnt families have been implicated to induce and pattern the ventral 
mesoderm (Munoz-Sanjuan and A, 2001). It is also widely believed that a morphogenic 
gradient of BMP signaling across the dorso-ventral axis during gastrulation is primarily 
responsible for patterning mesoderm into distinct cell fates (Dale and Wardle, 1999) 
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Figure 1.8 A model for the events and molecules involved in hematopoiesis.  
Hematopoietic stem cells (HSCs) arise from the ventral mesoderm through an 
intermediate precursor with both endothelial and hematopoietic potential, the 
hemangioblast. BMP signaling pathway plays critical roles in regulating several aspects 
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During the segmentation period at 10 to 12 hours post fertilization (hpf), both ICM and 
RBI express scl, lmo2 and gata2, together with the vascular markers, such as 
flk1(Carradice and Lieschke, 2008; Liao et al., 1997). As in mammals, the basic helix-
loop-helix transcription factor Scl (Tal1) and its partner Lmo2, which is a LIM domain 
transcriptional factor and functions as a bridging molecule, sit at the apex of 
hematopoietic and endothelial development (Carradice and Lieschke, 2008; Robb et al., 
1995; Shivdasani et al., 1995). In zebrafish, scl expression marks the formation of 
primitive HSCs and also vascular precursors, known as angioblasts. Knockdown of scl by 
antisense mropholinos results in the loss of primitive and definitive hematopoietic cell 
lineages without loss of lmo2 and gata2 expression, while ectopic scl expression leads to 
induction of lmo2 and expansion of both blood and endothelial precursors at the expense 
of somatic and pronephronic tissues (Dooley et al., 2005; Gering et al., 1998; Gering et 
al., 2003). Gata2 is a member of the zinc-finger family of transcription factors that bind 
to the consensus core sequence WGATAR (Orkin, 1992). Gata2 is expressed in 
hematopoietic and endothelial lineages and is required for the proliferation of 
hematopoietic progenitor cells. Gata2-deficient mouse embryos are anemic and die 
before HSC induction and expansion (Tsai et al., 1994). The co-expression of scl, lmo2 
and gata2 in ICM and RBI presumably represents the formation of the hemangioblast 
population (Hsia and Zon, 2005) (Figure 1.8). 
In the ICM, initial erythropoietic events begin at the 5-somite stage (approximately 12 
hpf) with expression of gata1 in a subset of scl+ cells (Detrich et al., 1995). Gata1 is 
another zinc-finger transcription factor. These scl+/gata1+ cells will eventually give rise 
to the first circulating blood cells, whereas the scl+/gata1- cells are believed to be 
Chapter I                                              Introduction 41 
angioblasts, as they differentiate into endothelial cells that specifically express the 
vascular endothelial growth factor receptor flk1/vegfr2 (Davidson et al., 2003; Liao et al., 
1997; Sumoy et al., 1997). This suggests that ICM precursors adopt either HSC or 
vascular fate by 5-somite stage. Following the formation of presumptive HSCs, there is a 
sequential activation of transcription factors critical for erythroid development, such as 
Tif1γ (moonshine), and Biklf (Davidson and Zon, 2004; Ransom et al., 2004).  
The erythroid precursors-proerythroblasts undergo extensive proliferation. By the time 
blood circulation begins around 24 hpf, there are at least 300 proerythroblasts in the ICM 
(Long et al., 1997). The circulating proerythroblasts expressing embryonic globins 
synchronously mature into flattened erythrocytes with elliptical shape over the next 4 
days and are later gradually replaced by erythrocytes originated from definitive HSCs 
resident in the pronephros. Unlike red blood cells in mammal, teleost erythrocytes remain 
nucleated for the lifespan of the fish (Davidson and Zon, 2004; de Jong and Zon, 2005).  
Unlike the ICM, the RBI region does not express gata1 and is devoid of erythropoietic 
activity, but instead undergoes myelopoiesis and granulopoiesis (Bennett et al., 2001). 
This is evidenced by expression of the myeloid-specific transcription factor gene pu.1 (or 
spi1, a member of the ets family of transcription factors) in a subpopulation of scl+ cells. 
Subsequently, more myeloid-specific markers, such as fms and l-plastin, start to express 
in the same cells (Bennett et al., 2001; Lieschke et al., 2002). These pu.1+ cells 
eventually develop into mature macrophages. It is reported that they are able to migrate 
to sites of infection and remove bacteria, such as Escherichia coli or Bacillus subtilis, by 
phagocytosis at 30 hpf (Herbomel et al., 1999). It is not known whether these 
macrophages from RBI present transiently as primitive macrophages, which are later 
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replaced by definitive HSCs derived macrophages, or they are retained permanently into 
adulthood (Davidson and Zon, 2004).  
Interesting, vascular cells are also derived from RBI. Thus, the two sites of primitive 
hematopoiesis show contrasting potentials to differentiate into erythroid (ICM) or 
myeloid (RBI) cells, and share the similar ability to generate vascular cells (Davidson and 
Zon, 2004).  
In fact, pu.1 expression is also found at a low level in ICM, between 10 to 19-somite 
stages (Bennett et al., 2001; Lieschke et al., 2002). The equilibrium of gata-1 and pu.1 
expression controls the balance between primitive erythroid and myeloid cell production 
within the ICM. In gata1−/− zebrafish embryos, pu.1 expression persists longer in the 
ICM than in wild-type embryos. In contrast, other early hematopoietic markers, including 
scl, lmo2 and gata2, all have normal expression in the gata1−/− embryos. The early ICM 
blood precursors in the gata1−/− embryos are mostly converted into myeloid cells, 
suggesting that Gata1 not only acts to promote erythroid development but also to 
suppress myeloid cell fate (Galloway et al., 2005). Work from several groups has 
suggested that PU.1 and GATA-1 antagonize one another through direct physical 
interaction (Nerlov et al., 2000; Rekhtman et al., 1999; Zhang et al., 1999; Zhang et al., 
2000).  
In addition, around 18-20 hpf, first granulocytes (similar to mammalian neutrophils and 
eosinophols) expressing specific marker myeloperoxidase (Mpo, an enzyme that is a 
major component of neutrophil and eosinophil granules) are identified in the posterior 
ICM and later migrate to a site of injury, such as tail clipping (Bennett et al., 2001; 
Lieschke et al., 2001). 
Chapter I                                              Introduction 43 
1.3.5 Tanscriptional Regulation Of Definitive Hematopoiesis 
At approximately 24 hpf, levels of hematopoietic transcription factors begin to diminish 
in the primitive sites, as hematopoiesis shifts to the definitive wave. Definitive HSCs, 
which are capable of unlimited self-renewal and able to generate all mature 
hematopoietic lineages, are found in the ventral wall of the dorsal aorta in zebrafish 
(equivalent to mammalian AGM), where expression of definitive HSC markers c-myb 
and runx1 are detected between 24-48 hpf. Around 4-5 dpf, HSCs aggregate in the 
kidney, thymus and pancreas. The kidney becomes the main lifelong location of zebrafish 
hematopoiesis (de Jong and Zon, 2005) (Figure 1.7). 
c-myb gene encoded protein contains an N terminal DNA-binding domain, a central 
transactivation domain and C-termianl negative regulatory domain (Vandenbunder et al., 
1989). The transactivation domain interacts with p300 and controls the proliferation and 
differentiation of HSCs (Sandberg et al., 2005). Loss of c-myb in mice results in severe 
anemia due to impaired definitive hematopoiesis without perturbation of embryonic 
hematopoiesis (Mucenski et al., 1991; Mukouyama et al., 1999). Runx1 contains a runt 
domain and is a key component of transcription complex. Knock-down of runx1 in 
zebrafish embryo leads to accumulation of immature hematopoietic progenitors, loss of 
blood circulation and incomplete vascular development (Kalev-Zylinska et al., 2002; 
Levanon et al., 1994). Other transcription factor including ikaros, lmo2 and scl are also 
expressed in the AGM (Thompson et al., 1998). The Ikaros gene product belongs to zinc 
finger family of transcription factors. Long form of Ikaros consists of two zinc fingers, an 
N-terminal finger domain mediating DNA binding and C-terminal domain mediating 
dimerization. Generally, Ikaros proteins modulate transcription by recruiting corepressor 
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complex to the promoters of target genes and/or sequestering transcriptional coactivators 
(Koipally et al., 1999; Sabbattini et al., 2001; Trinh et al., 2001). Intriguingly, several 
isoforms of Ikaros are differentially expressed at various stages of hematopoiesis, 
suggesting that regulated expression of Ikaros isoforms could provide fine regulation for 
hematopoiesis (Klug et al., 1998). 
At 48 hpf, a subset of the ikaros+ cells in the AGM are likely candidates for lymphoid 
progenitors that eventually seed the thymus (Willett et al., 2001). As the thymus 
continues to grow over the next a few days, a number of small mature lymphocytes 
aggregate in the thymic epithelium, expressing characteristic T cell genes, including 
gata3, ikaros, T cell receptor kinase lck, and the recombination activating genes rag-1 
and rag-2 (Willett et al., 1997). Zebrafish adaptive immune system is composed of T 
cells expressing rearranged antigen-specific T cell receptors and B cells expressing 
immunoglobulins. In contrast to T cell development in the thymus, B cell development is 
established in the kidney marrow by 19 dpf (Davidson and Zon, 2004; de Jong and Zon, 
2005).  
In addition, definitive hematopoiesis produces nucleated blood cells-zebrafish 
thrombocytes. Thrombocytes function similarly as mammalian platelets to maintain 
hemostasis by facilitating clot formation (Jagadeeswaran et al., 1999). In mammal, 
multinucleated giant megakaryocytes in the bone marrow are known as precursors of 
platelets. However, no similar precursors have been identified, although transcription 
factors important for megakaryocyte development are present in zebrafish, including 
gata1, fli1, fog1, nfe2 and runx1 (Burns et al., 2002; Pratt et al., 2002; Schulze and 
Shivdasani, 2004). 
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In summary, the transcriptional regulation of zebrafish hematopoiesis is highly conserved 
compared to mammalian system. The high degree of conservation refers to the factors 
themselves and also the sequence of their action. The conserved regulatory hierarchy 
makes zebrafish mutants useful tools to study related human diseases (Table 1.1).  
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Adapted from de Jong and Zon, 2005, with slight modification. 
1.3.6 Regulation Of Hematopiesis By Cytokines and Growth factors  
The process of blood cell formation is not only regulated by a variety of intrinsic 
transcription factors, multiple intracellular and extracellular signaling molecules are also 
involved in hematopoietic regulation, such as type III receptor tyrosine kinase receptors 
(RTK), interleukin-3/5 (IL-3/5), erythropoietin (EPO) and its receptor. Furthermore, 
Hedgehog, Vegf, Notch, TGF-β and BMP signaling pathways are also shown to play 
essential roles in both primitive and definitive hematopoiesis (Carradice and Lieschke, 
2008).  
Type III receptor tyrosine kinase  
The hematopoietic receptor of type III RTK Flt3 (fms-like tyrosine kinase 3) is 
characterized by five immunoglobulin-like domains in the extracellular (EC) region of 
the receptor, followed by a transmembrane (TM) and juxtamembrane (JM) domain, a 
split kinase domain (KD) containing a kinase insert (KI) region, and a C-terminal (CT) 
tail (Rosnet and Birnbaum, 1993; Rosnet et al., 1993). Type III RTKs are normally 
involved in the regulation of hematopoiesis or hematopoietic cell function (Reilly, 2003a; 
Reilly, 2003b; Rosnet and Birnbaum, 1993). Despite differences in structure, normal 
function, and subcellular location, many of them signal through the phosphorylation of 
STATs (signal transducers and activators of transcription), and typically enhance 
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proliferation and prolong viability (Spiekermann et al., 2003). RTKs are known as 
oncogenes when mutations induce their constitutive kinase activities (Porter and 
Vaillancourt, 1998).  
Interleukin-3/5 signaling 
Interleukin 3 promotes development of hematopoietic cells through activation of the IL-3 
receptor (IL-3R) complex consisting of α and β subunits. The α subunit provides the 
specificity to cytokines and β plays a major role in signal transduction (Hara and 
Miyajima, 1996). IL-3, GM-CSF (granulocyte-macrophage colony-stimulating-factor) 
and IL-5 exhibit similar functions (Warren and Moore, 1988). However no apparent 
hematological defect other than a reduced number of eosinophils was found in knock-out 
mice lacking an entire function of IL-3, GM-CSF and IL-5, indicating a remarkable 
functional overlap with other cytokine systems for hematopoiesis (Hara and Miyajima, 
1996; Nishinakamura et al., 1996; Warren and Moore, 1988). Binding of these cytokines 
to the receptor leads to activation of the Janus family tyrosine protein kinase 2 (JAK2) 
and STAT5, as well as induction of c-myc. (Hara and Miyajima, 1996).  
Erythropoietin signaling 
Erythropoietin, which is produced by the kidney and liver in response to hypoxia or 
anemia, is the primary regulator of red blood cell production. It controls proliferation, 
maturation and also survival of erythroid progenitor cells (Spivak, 1986). The binding of 
EPO to its dimer receptor induces a conformational change that brings JAK2 molecules 
in close proximity and stimulates their activation by transphosphorylation. In turn, JAK2 
molecules phosphorylate tyrosine residues in the cytoplasmic domain of the EPO 
receptor, which then serve as docking sites for various intracellular signaling proteins 
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which contain Src homology 2 (SH2) domains. For example, the transcription factor 
STAT5 can bind to activated EPO receptors, become phosphorylated, homodimerized and 
translocated into the nucleus to activate target genes. Other pathways activated by the 
EPO receptor through protein phosphorylation include the Ras/MAP kinase and 
phosphatidylinositol 3-kinase (PI3-kinase) pathways (Foley, 2008; Fried, 2009).  
In addition, Epo and other cytokine-activated intracellular signal transduction cascades, 
such as the JAK-STAT pathway, are negatively regulated by the suppressor of cytokine 
signaling (SOCS) family of proteins respect to both magnitude and duration (Croker et 
al., 2008; Jegalian and Wu, 2002). SOCS proteins are upregulated in response to cytokine 
stimulation and inhibit cytokine induced signaling pathways, forming a classical negative 
feedback circuit. They participate in inactivation of JAKs, blocking access of the STATs 
to receptor binding sites, and ubiquitinating signaling proteins and subsequently targeting 
them to the proteasome (Kile and Alexander, 2001). The analysis of socs1 deficient mice 
has revealed that SOCS1 plays a key role in T cell differentiation (Catlett and Hedrick, 
2005; Tanaka et al., 2008). Additionally, the study of embryos lacking socs3 has revealed 
the function of SOCS3 in fetal liver hematopoiesis (Marine et al., 1999).  
Hedgehog signaling 
Hedgehog signaling is essential for proper pattern formation and morphogenesis in 
several species (McMahon, 2000). In mouse, there are three homologs of the Drosophila 
Hedgehog (Hh) gene: Sonic hedgehog (Shh), Desert hedgehog (Dhh) and Indian 
hedgehog (Ihh) (Echelard et al., 1993; Hammerschmidt et al., 1997). All three hedgehogs 
signal through Patched (Ptch), a twelve-pass membrane receptor, and Smoothened (Smo), 
a seven-pass G protein like molecule. Binding of Hh to Ptch releases inhibition of Smo, 
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which in turn initiates the activation and nuclear translocation of the cubitus interruptus 
(Ci) transcription factors: Gli1, Gli2 and Gli3. Downstream target genes include Ptch as 
well as Bmps (Denef et al., 2000; Murone et al., 1999a; Murone et al., 1999b).  
A conditional ablation strategy in adult mice shows that the development of T and B 
lymphoid cells is blocked at the level of the common lymphoid progenitor in the bone 
marrow, when Ptch is absent. In contrast, cells of the myeloid lineage develop normally 
in Ptch mutant mice (Uhmann et al., 2007). Therefore, HH/Ptch signaling is critical for 
the induction of lymphoid versus myeloid lineage commitment. In addition, a role for Ihh 
in yolk sac function is also suggested. 50% of Ihh–/– mice die at mid-gestation, potentially 
due to vascular defects in the yolk sac. Embryoid bodies (EB) derived from Ihh or Smo 
deficient embryonic stem cells are unable to form blood islands, and express reduced 
levels of endothelial cell markers. Ihh–/– lines also show a substantial decreased scl 
expression, markers for the hemangioblast (Byrd et al., 2002).  
VEGF and receptors 
VEGF monomers linked by disulfide bonds induce receptor dimerization, thereby 
triggering the activation of both the receptor itself and several cytoplasmic signal 
transduction molecules including VEGFR associated protein (VRAP), Ras GTPase 
activating protein (Ras GAP), Src family of tyrosine kinases, PI3-kinase, STAT and so 
on. There are also many co-receptors of VEGFR kinase, such as Cadherins, Integrin, 
Neuropilin 1 and 2 (Li et al., 2008). 
The role of vascular endothelial growth factors (VEGF) and their receptors (VEGFR) has 
been studied extensively due to their important roles during blood vessel formation 
(Cebe-Suarez et al., 2006). Mice deficient in various VEGF ligands or receptors show 
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serious defects in vascular formation and maturation (Matsumura et al., 2003). Moreover, 
members of the VEGF family are not only involved in angiogenesis, but also in 
hematopoiesis. For example, decreased level of VEGF and Ihh attenuates definitive 
hematopoietic progenitor cell expansion in Gata4 and Gata6 null embryoid bodies. 
Furthermore, VEGF and Ihh can rescue definitive hematopoiesis in these Gata-4/Gata-6 
deficient murine EBs (Pierre et al., 2009). 
Notch/Jagged pathway 
The Notch1-Jagged pathway plays an important role in integrating extracellular 
regulatory signals with hematopoietic stem cell cycling control (Karanu et al., 2000). 
Following binding of the Notch1 receptor by extracellular ligand, cleavage events release 
the intracellular portion of Notch1, which in turn translocates to the nucleus and acts as a 
transcription factor on its target genes (Kopan and Ilagan, 2009). Constitutively over-
expressing the intracellular domain of Notch1 in hematopoietic cells establishes 
immortalized cell lines with the potential to reconstitute myeloid and lymphoid cell 
lineages both in vivo and in vitro (Varnum-Finney et al., 2000). Addition of Notch ligand 
jagged-1 can also prompt the pluripotency of the CD34+CD38-Lin- cord blood cells 
(Karanu et al., 2000). 
TGF-βs  
TGF-β molecules belong to a large superfamily of transforming growth factors that 
control cell growth, differentiation, and apoptosis (Massague et al., 2000). Depending on 
the differentiation status of target cells, the local environment and concentration and 
isoform of TGF-βs (Larsson and Karlsson, 2005), they are pluripotent regulators in a 
number of steps of hematopoiesis. For example, in myeloid and erythroid leukemic cells, 
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autocrine TGF-β1 and/or its Smad signals control the ability of these cells to respond to 
various differentiation inducers, suggesting that this pathway plays a role in determining 
the cell fate of leukemic cells (Kitisin et al., 2007; Lin et al., 2005; Massague et al., 
2000). The mammalian TGF-β1, 2 and 3 have distinct but overlapping effects on 
hematopoiesis. TGF-β ligand binds to a heteromeric complex of type I (TβRI) and type II 
(TβRII) serine/threonine kinase receptors. Following ligand binding, TβRII recruits and 
activates TβRI, which in turn phosphorylates downstream targets, including the receptor 
activated Smad proteins (R-Smads), which are phosphorylated on their C-terminus and 
then translocate to the nucleus in complex with the common mediator Smad4 (Co-Smad) 
to regulate transcription of target genes. The principal R-Smads are Smad2 and Smad3 
for TGF-β signaling. In the nucleus, Smad proteins can bind directly to their cognate 
DNA-binding sites and/or interact with transcriptional coactivators or repressors 
(Attisano and Wrana, 2002).  
Recent studies have shown that there is extensive crosstalk between TGF-β/Smad 
signaling pathway and ERK, p38, c-Jun N-terminal kinase (JNK) and MAPK signaling 
cascades. For example, a novel MAPK kinase kinase (MAPKKK) termed TGF-β-
activating kinase (TAK1) participates in signal transduction of TGF-β1 and has been 
shown to activate both the p38 and JNK pathway (Derynck and Zhang, 2003; Guo and 
Wang, 2009).  
BMPs 
BMPs also belong to the transforming growth factor-β superfamily of secreted proteins, 
and signal via the downstream transcription factors, Smad-1, -5, and -8 (von Bubnoff and 
Cho, 2001). Recently, more and more work has shown that BMP signaling is important 
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not only for the patterning of ventral mesoderm from where the primitive HSCs arise, but 
also for regulating proliferation and specification of blood progenitors (Figure 1.8). 
BMP/Smad signaling regulates hematopoiesis by crosstalk with other regulatory signals, 
so the outcome is very context dependent (Larsson and Karlsson, 2005; Winnier et al., 
1995). 
Work in Xenopus embryos suggests a model for primitive HSC formation. During 
gastrulation, BMP4 transcriptionally induces expression of homeobox genes such as 
Mix.1 and Vent-1 via xMad1. These homeobox genes directly or indirectly induce the 
expression of transcription factors Scl and Gata2, marking the formation of 
hemangioblast (common precursor for hematopoietic and endothelial cells) (Huber and 
Zon, 1998). In fact, a large number of studies in several other species have confirmed the 
key role of BMP signaling in hematopoietic commitment (Larsson and Karlsson, 2005; 
Snyder et al., 2004). Mice lacking BMP4 die between E7.5 and E 9.5 with severe defects 
in mesoderm formation. Those embryos, which survive up to E9.5 show defective blood 
island (Winnier et al., 1995). Similar to the studies using mouse embryonic stem (ES) 
cells, addition of BMP and cytokines promotes the hematopoietic differentiation of 
human ES cells (Chadwick et al., 2003; Johansson and Wiles, 1995; Park et al., 2004). 
Strikingly, studies by Jay et al demonstrate that BMP4, in combination with various 
cytokines, including erythropoietin (EPO), is able to induce several blood lineages from 
human skeletal or neural tissues (Jay et al., 2002). Finally, dorsalized zebrafish mutants 
of BMP pathway components usually have defective blood system. For example, zygotic 
laf  (mutant for type I BMP receptor alk8) mutant embryos lack the ventral tail fin and 
vein at 1 dpf. They fail to develop blood circulation and die by 3 dpf (Mintzer et al., 
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2001). In contrast, ventralized din mutant (mutant for bmp antagonist Chordin) show 
expanded blood island and expanded hematopoietic gene expression (Kawahara and 
Dawid, 2000; Leung et al., 2005; Schulte-Merker et al., 1997). Therefore, hematopoietic 
commitment requires intact BMP signaling.  
However, it is not clear how many steps and what factors are involved between ventral 
mesoderm patterning and the specification of hemagioblast. In another word, it is not 
known what controls the separation of blood/endothelia cell (BC/EC) lineages from other 
ventral mesoderm cell types. Observations in chick embryo suggested some clues. During 
embryonic development in amniotes, the extra-embryonic mesoderm, where the earliest 
hematopoiesis and vasculogenesis take place, also generates smooth muscle cells 
(SMCs). Chick extraembryonic SMC and blood/endothelia cell (BC/EC) lineages are 
segregated early, and are marked by dHAND and Scl, respectively. It is proposed that 
once ventral mesoderm is specified by active BMP signaling, blood/endothelia cell 
(BC/EC) specification takes place as a default choice. SMC differentiation is promoted 
by canonical Wnt signaling and the balance between SMCs and BC/ECs is mediated by 
Notch signaling. Another possibility is that graded levels of BMP activity have 
discernable effect on Scl or dHand expression, resulting in qualitative differences in 
SMCs or BC/ECs induction (Shin et al., 2009) (Figure 1.8). 
Apart from important function in specification of primitive HSCs, described above, BMP 
signals have been shown to regulate definitive hematopoiesis as well. BMP4 signaling is 
important in mediating shh-induced proliferation (Bhardwaj et al., 2001). BMP4 is shown 
to positively regulate both proliferation and survival of human blood progenitors 
(Larsson and Karlsson, 2005). Work by McReynolds show that zebrafish embryos 
Chapter I                                              Introduction 54 
depleted for Smad1 fail to produce mature embryonic macrophages, where Smad5 
depleted embryos are defective in primitive erythropoiesis. Loss of either Smad1 or 
Smad5 causes a failure in the generation of definitive hematopoietic progenitors 
(McReynolds et al., 2007). Furthermore, as I mentioned in chapter 1.3.1.4, the Smad5 C 
terminal truncated isoform smad5β is expressed higher in CD34+ hematopoietic stem 
cells than in terminally differentiated peripheral blood leukocytes, implicating the 
function of β form in hematopoietic stem cell homeostasis. It is also indicated that the 
proper splicing of smad5 is important for normal adult hematopoietic development (Jiang 
et al., 2000). However, conditional knock-out mice for BMP type I receptor, BMPRIA, 
have increased numbers of spindle-shaped N-cadherin+CD45- osteoblastic (SNO) cells in 
the stem cell niche, leading to an increase in the number of definitive HSCs in these mice. 
It is postulated that SNO cells lining the bone surface function as a key component of the 
niche to support HSCs, and that BMP signalling through BMPRIA controls the number 
of HSCs by regulating niche size (Zhang et al., 2003). 
In summary, BMP signaling activity plays essential role in both primitive (embryonic) 
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1.4 RESEARCH OBJECTIVE 
The Integrator complex proteins are identified to directly interact with RNA polymerase 
II to mediate 3’end processing of U1 and U2 snRNAs. Integrator subunit 5 (Ints5) is 
picked up in a screen searching for genes acting in Drosophila oogenesis. It is found that 
the BMP homologue, DPP signaling is affected in ints5 depleted germarial cells, leading 
to production of immature oocytes (Cai et al., unpublished data). This work indicates the 
role of Ints5 in regulating BMP signaling during vertebrate development. More 
improtantly, I found that knock-down of ints5 in early zebrafish embryo leads to a lack of  
blood circulation, reduced expression of the hematopoietic genes and arrested red blood 
cell differentiation. It is long known that hematopoiesis, the dynamic process of blood 
cell development, is regulated by the activity of the Bone Morphogenetic Protein (BMP) 
signaling pathway and many transcription factors. Therefore, my research focused on 
studying the function of Integrator subunits in hematopoiesis. The detailed analysis of 
Ints5 function will reveal the link between the housekeeping snRNA processing 
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2.1 ZEBRAFISH MAINTENANCE AND STRAINS 
2.1.1 Fish Maintenance And Embryos Culture 
Zebrafish were maintained under standard conditions at 28.5°C and embryos were 
obtained by standard breeding methods. All experimental procedures were carried out 
according to the guidelines of the Institutional Animal Care Use Committee at Temasek 
Life Sciences Laboratory as described in the Zebrafsih book (Westerfield, 2000). 
Embryos were collected after natural mating and raised in egg water (0.03% sea salt) at 
28.5°C. Embryos were staged by hours post fertilization (hpf) and according to standard 
staging criteria according to Kimmel (Kimmel et al., 1995). 
2.1.2 Fish Strains Used For The Studies 
The zebrafish wild type (WT) strain AB (Johnson et al., 1994) was used for embryo 
injection and protein extraction. 
 
2.2 CLONING OF INTEGRATOR SUBUNITS 
2.2.1 5’ and 3’ Rapid Amplification Of cDNA Ends (RACE)-Ints5 Cloning 
Total RNA was extracted from wild-type embryos and subjected to 5’and 3’RACE using 
the FirstChoice RLM-RACE Kit (Ambion #AM1700) according to manufacturer’s 
instructions. The following primers were used: 
Ints5 5’Race 1: 5’ TCACCCTATGCAGGCCTTGTAGA 3’ 
Ints5 5’Race 2: 5’ GGGAGTAGCACTCCATTAGTGA 3’ 
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Ints5 3’Race 1: 5’ GCTACTTCCTCCAGTCTTGAGT 3’ 
Ints5 3’Race 2:  5’ CGCTGTGCTATTGCTCTGTCAT 3’  
The RACE products were cloned with BamHI and XhoI into the plasmid pCS2+ and 
sequenced. 
2.2.2 Cloning Of Ints3, Ints6, Ints7, Ints9, Ints10, Ints11 and Ints12 
ints3 was amplified from cDNA template with primer pair: 
Ints3 F 5’CCATCGATGGTGCCCTGCGGAAGTTGAAT 3’ 
Ints3 R 5’AACCAAACATTTCCGCCCTT 3’ 
PCR product was cloned with ClaI and EcoRI into pCS2+ and sequenced. 
 
ints6 was amplified from cDNA template with primer pair: 
Ints6 F 5’ CCGCTCGAGCGGCCGATTGTAGCTATTTTAGAC 3’ 
Ints6 R 5’ CCGCTCGAGCGGAACCCCTATCGAACCTGGAA 3’ 
PCR product was cloned with XhoI into pCS2+ and sequenced. 
 
ints7 was amplified from cDNA template with primer pair: 
Ints7 F 5’ GGAATTCATAAACAATGTCGCTTTCAGCAGC 3’ 
Ints7 R 5’ GCTCTAGAATGAGGAGAGCACCACAGAAC 3’ 
PCR product was cloned with EcoRI and XbaI into pCS2+ and sequenced. 
 
ints9 was amplified from cDNA template with primer pair: 
Ints9 F 5’ CCGGAATTCGGAGGTATCGCTAAATATGC 3’ 
Ints9 R 5’ CCGCTCGAGGACAAGCATCAACATACACCG 3’ 
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PCR product was cloned with ClaI and XhoI into pCS2+ and sequenced. 
 
ints10 was amplified from cDNA template with primer pair: 
Ints10 F 5’ CCATCGATGGAAGAAAACAGAGCAGATGTCCG 3’ 
Ints10 R 5’ GCTCTAGAGACACACACACACAGCTTATGAGG 3’ 
PCR product was cloned with ClaI and XbaI into pCS2+ and sequenced. 
 
ints11 was amplified from cDNA template with primer pair: 
Ints11 F 5’ CGCGGATCCGCGCTGTGTTGGAGTTGACATATC 3’ 
Ints11 R 5’ CCGCTCGAGGTTTCAGCAGTCAAGAAGGCAGACC 3’ 
PCR product was cloned with BamHI and XhoI into pCS2+ and sequenced. 
 
ints12 was amplified from cDNA template with primer pair: 
Ints12 F 5’ CCATCGATCGCTAAACAATGGCTGGGACAG 3’ 
Ints12 R 5’ CCGCTCGAGGACATTCTGCCTACTTCCTCC 3’ 
PCR product was cloned with ClaI and XhoI into pCS2+ and sequenced. 
 
2.3 SMAD CONSTRUCTS 
pCSsmad5∆Exon4 and pCSsmad5∆Exon4, 5 were generated by over-lapping PCR 
amplification from cDNA templates (Dick et al., 1999) using the following primers:  
smad5 5’ F: 5’CGGGATCCTCCTGTCCTTGGTCCTGCAA3’ 
smad5 3’UTR R: 5’CGGAATTCCCTATGCTAGATGTGCTTGT3’ 









PCR products were cloned into pCS2+ with BamHI and EcoRI. 
 
2.4 RNA AND MORPHOLINOS INJECTIONS 
2.4.1 mRNA Synthesis 
For injection, constructs were digested with NotI and the capped mRNA was synthesized 
with the mMessage mMachine SP6 kit (Ambion # 1340) according to manufacturer’s 
instructions.   
Linearized DNA                                                 1-2 µg 
10 x Reaction Buffer                                              2 µl 
2 x NTP/cap                                                         10 µl 
SP6 Enzyme Mix                                                   2 µl 
DEPC treated water was added to a final volume of 20 µl. Then, the reaction was 
incubated at 37°C for 2 h. Following this, 1 µl of DNase I was added and the reaction 
was incubated further at 37°C for 30 min.  
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The reaction was stopped by adding 15 µl of ammonium acetate. Then, 115 µl of distilled 
sterile DEPC (Diethylpyrocarbonate) treated water and 150 µl of 
phenol/chloroform/isoamyl alcohol (Sigma #P3803) were added into the tube. After 
mixing and centrifugation, the aqueous phase was transferred to a fresh tube. To 
precipitate the capped mRNA, 150 µl of isoproponal was added to the tube and it was 
kept at -80°C for half an hour or -20°C overnight. After centrifugation, the RNA pellet 
was washed with 1 ml of 75% ethanol, air-dried and dissolved in 20 µl of distilled sterile 
DEPC treated water. The quality and quantity of the capped mRNA was determined by 
measuring the optical density (OD). 
2.4.2 Injection Of Morpholinos 
All morpholinos were obtained from GeneTools company (www.gene-tools.com). The 
ints5 donor and acceptor morpholinos were designed to target the splice sites.  Co-
injection of two ints5 morpholinos (donor + acceptor MO) at an optimal dose of 2.5 ng+ 
2.5 ng/embryo was found to be more efficient, therefore all injections, unless otherwise 
specified, were performed using this combination. The ints9 splice morpholino (ints9 
SMO) targeting the intron2-exon3 boundary of ints9 was used at a dose of 12.5 
ng/embryo. The ints11 ATG morpholino (ints11 ATG MO) were injected at a dose of 25 
ng/embryo. The ints11 splice morpholino (ints11 SMO) targeting the intron4-exon5 
boundary was injected at a dose of 2.5 ng/embryo. The morpholino sequences are listed: 
ints5 donor MO: 5 CTTGTATTGCTCACCTGTAA 3’ 
ints5 acceptor MO: 5’AGCTCTTGAGGACTGATGGA 3’ 
ints9 SMO: 5’GATAATCGTGGACTGTAAATCCAAC3’ 
ints11 ATG MO: 5’ AAGGCGTAACTTTGATATCAGGCAT3’ 
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ints11 SMO: 5’AGATGGAAATGACTGAGAGGAAGAG3’ 
For rescue experiments, 50 pg of ints5 RNA and 10 pg of smad1 or smad5 RNA was co-
injected with ints5 morpholinos. 
2.4.3 Embryo Injection And Fixation  
Different doses of mRNA and morpholinos were injected into one-cell stage embryos and 
embryos were either fixed at different stages using 4% paraformaldehyde (PFA) (Sigma 
#P-6148) or were raised until 24 hours for phenotypic observation. 
 
2.5 WHOLE MOUNT RNA IN SITU HYBRIDIZATION ANALYSES  
2.5.1 Digoxigenin (DIG) Or Fluorescein (FLU)-Labeled RNA Probe Synthesis 
Linearization of plasmids 
Plasmids were linearized by the restriction enzyme near the 5’ cloning site and purified 
from gel by using a QIAquick Gel Extraction Kit (Qiagen #28706).  
The following plasmids were linearized and antisense probes were synthesized by in vitro 
transcription:  
pBSints5: BamHI/T3 RNA Polymerase (Baillat et al., 2005) 
pGEMT-Easyscl: NcoI/SP6 RNA Polymerase (Gering et al., 1998) 
pBSgata1: XbaI/T7 RNA Polymerase (Detrich et al., 1995) 
pBSflk1: SmaI/T7 RNA Polymerase (Liao et al., 1997) 
pKSpax2a: BamHI/T7 RNA Polymerase (Majumdar et al., 2000) 
pBShgg1: XbaI/T7 RNA Polymerase (Thisse et al., 1994) 
pBSgsc: EcoRI/T7 RNA Polymerase (Thisse et al., 1994) 
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pBSntl: XhoI/T7 RNA Polymerase (Schulte-Merker et al., 1994) 
pBSspt: EcoRI/T7 RNA Polymerase (Griffin et al., 1998) 
pBSsox17: EcoRI/T7 RNA Polymerase (Alexander and Stainier, 1999) 
pBSmyoD: BamHI/T7 RNA Polymerase (Weinberg et al., 1996) 
pBSdlx3: SalI/T7 RNA Polymerase (Akimenko et al., 1994). 
The in vitro transcription reaction: 
5 X transcription buffer (Promega #P118B)                                                         10 µl 
RNA polymerase (SP6 polymerase, Promega #P108B;                                         2 µl 
T7 RNA polymerase, Promega #P2075 and T3 RNA  
polymerase, Promege #P2083.) 
10 X DIG RNA labeling mix (Roche #1277073910)                                             5 µl 
or 10 X Fluorescein RNA labeling mix (Roche #1685619) 
RNase inhibitor (Roche #03335399001)                                                                1 µl 
100 mM DTT (Promega #117B)                                                                             1 µl 
linearized DNA template                                                                                    1-2 µg 
Distilled, sterile DEPC treated H2O was added to a final volume of 50 µl, and incubated 
at 37°C for 2 h. 
Then, 1 µl of DNase I recombinant, RNase-free (Roche # 04 716 728 001) was added to 
the above reaction, incubated at 37°C for 30 min. 
The reaction was stopped by adding 1 µl of 0.5 M EDTA (pH 8.0). Labelled RNA was 
precipitated by adding 5 µl LiCl (4 M), 100 µl cold isopropanol, and incubated at –20°C 
overnight. After centrifuging, the RNA pellet was washed with 75% cold ethanol and 
then air dried and dissolved in 50 µl DEPC treated sterile H2O. The quality and quantity 
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of the RNA was determined by measuring its OD. The probe stocks were stored at –
80°C. 
For in situ hybridization, the DIG-labeled or Flu-labeled probe was diluted in 60% 
hybridization buffer (hyb) to a final concentration of 100 ng probe/200 µl hyb and stored 
at –20°C. 
The components of 60% hybridization buffer are as follows:  
5 x Standard Sodium Citrate (SSC) 
60% Formamide 
0.1% Tween 20 (SIGMA-ALDRICH #P9416) 
1 mg/ml tRNA (Roche #109 509) 
100 µg/ml heparin (SIGMA-ALDRICH #A6039) 
1 x Denhardt’s solution 
0.1% CHAPS 
10 mM EDTA  
2.5.2 In Situ Hybridization Procedure 
Embryos were fixed in 4% PFA, incubated at room temperature (RT) or 4°C overnight. 
Embryos were washed with PBST (0.1% Tween 20 in phosphate buffered saline, PBS) 
three times, followed by dechorionation using forceps under the dissecting microscope. 
Dechorionated embryos were gradually dehydrated in 25%, 50%, 75% and 100% 
methanol, and stored at –20°C for later use. The whole-mount in situ hybridization 
analysis was performed according to Tian Jing (Tian et al., 2003). 
Day I: Pre-hybridization and hybridization 
Embryos were rehydrated gradually from methanol to PBST. Embryos older than 24 hpf 
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need proteinase K treatment (3 µg/ml for 24 h embryos, 100 ng/ml for 50% to 100% 
epiboly embryos) for better probe penetration. After proteinase K treatment for 1 min, 
embryos were post-fixed in 4% PFA for 20 min. Then, embryos were washed with PBST 
three times before incubation with 60% hyb buffer for at least 4 h at 65°C. Then the 
diluted probes were added to embryos and incubated in the 65 °C water bath overnight. 
Day II: Post-hybridization washes and antibody incubation 
The non-hybridized RNA probes were washed away by the following buffers in 
sequence: 
50% formamide/5 x SSC (FS), 65 °C 10 min 
75% FS/25% 2 x SSC (0.1% Tween 20 in 2xSSC), 65°C 10 min 
50% FS/50% 2 x SSC, 65 °C 10 min 
25% FS/75% 2 x SSC, 65 °C 10 min 
2 x SSC, 65 °C 15 min for 2 times 
0.2 x SSC (0.1% Tween 20 in 0.2xSSC), 65°C 15 min for 2 times 
75% 0.2 x SSC/25% Maleic acid buffer (MAB) (0.1% Tween 20 in MAB), RT 10 min 
50% 0.2 x SSC/50% MAB, RT 10 min 
25% 0.2 x SSC/75% MAB, RT 10 min 
MAB, RT 10 min  
Embryos were incubated in 0.5% blocking reagent (Roche #11 096 176 001) in MAB at 
RT for at least half an hour, and then incubated with 1:2000 anti-Digoxigenin alkaline 
phosphatase (AP) antibody (for detecting DIG-labeled probe) (Roche #11093274910) or 
1:500 anti-Fluorescein-AP antibody (for detecting FLU-labeled probe) (Roche 
#11426338910) in blocking buffer at 4°C overnight. 
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Day III: Post-antibody washes and signal detection 
To wash out the unbound antibody, embryos were washed with MAB at room 
temperature, 15 min x 5 times. Embryos were then washed in Buffer 9.5 at RT 5 min x 3 
times.  
Then, the reaction was developed with the BM Purple AP substrate (Roche 
#11442074001). Embryos were stained with purple in color. 
Buffer 9.5: 
0.1 M Tris-HCl pH9.5 
0.1 M NaCl 
0.05 M MgCl2 
0.1% Tween 20 
Alternatively, embryos were washed in Buffer 8.2 at RT 5 min x 3 times. The reaction 
was developed with Fast Red substrate (Sigma # F4523). Embryos were stained with red 
in color. 
Buffer 8.2:  
0.1 M Tris-HCl pH8.2 
0.1 M NaCl 
0.05 M MgCl2 
0.1% Tween 20 
The excess substrate was washed away using PBST for two times and embryos were 
post-fixed in 4% PFA at 4°C overnight. For imaging, fixed embryos were washed again 
with PBST to remove PFA, and stored in 50%/50% glycerol/PBST at 4 °C. 
For two-color in situ hybridization, the embryos were washed in PBST for three times 
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and then in MAB buffer after the completion of the first staining. Then the embryos were 
re-blocked in 0.5% blocking buffer before adding the antibody for detecting the second 
probe, and the reaction was developed with a different substrate. 
 
2.6 TOTAL RNA EXTRACTION AND RT-PCR 
2.6.1 Total RNA Extraction  
Embryos were collected in 1 ml of TRIZOL (invitrogen) in an eppendorf tube and 
homogenized using a syringe with a 261/2 G needle. The homogenized samples were 
incubated for 5 minutes at room temperature to permit the complete dissociation of 
nucleoprotein complexes. Then 0.2 ml of chloroform (Sigma # C0549-1PT) was added 
into 1 ml of TRIZOL. The securely capped tubes were then vigorously inverted back and 
forth for 15 seconds and incubated at room temperature for 2 to 3 minutes. The samples 
were centrifuged at no more than 12,000 g for 15 minutes at 4°C. Upon centrifugation, 
the mixture separates into a lower pink phenol-chloroform phase, a white inter-phase, and 
a colorless upper aqueous phase. RNA remains exclusively in the aqueous phase.  The 
volume of the aqueous phase is about 0.6 ml. 
The aqueous phase was transferred to a fresh tube and the RNA was precipitated from the 
aqueous phase by mixing with 0.5 ml of cold isopropyl alcohol. After incubation at room 
temperature for 10 minutes, the samples were centrifuged at no more than 12,000 g for 10 
minutes at 4°C.  The RNA precipitates and usually forms a gel-like white pellet at the 
bottom of the tube.  
After removing the supernatant, the RNA pellet was washed with 1 ml of cold 75% 
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ethanol, and centrifuged at no more than 7,500 g for 5 minutes at 4°C. At the end of the 
procedure, the RNA pellet was air-dried for 5-10 minutes. RNA was dissolved in RNase-
free water and incubated for 10 minutes at 55 to 60°C. RNA can be stored at -80°C.  
2.6.2 DNase Treatment Of Total RNA 
The DNase treatment reaction was set as below: 
Total RNA                                                                                                   x µl 
10x DNase I buffer (Roche # 04 716 728 001)                                          5 µl 
RNAse inhibitor (Promega # N211A)                                                       1 µl 
100 mM DTT (Promega # P117B)                                                             1 µl 
DNase I (Roche # 04 716 728 001)                                                            1 µl 
Distilled, sterile DEPC treated H2O was added to a final volume of 50 µl, and the 
reaction was incubated at 37°C for 1 hour. 
Mix 50 µl of the above reaction with 100 µl of sterile DEPC treated H2O to make it up to 
150 µl and mix it well with 150 µl of phenol: chloroform: isoamyl alcohol (25:24:1, 
Sigma # P3803-100 ml). Following centrifugation at 12,000 g for 15 minutes at 4°C, the 
upper aqueous phase containing RNA was transferred to a new tube and mixed with 150 
µl of chloroform (Sigma # C0549-1PT). Following this, the phase separation, RNA 
precipitation, RNA washing and re-dissolving steps were repeated as described earlier. 
The RNA can be stored at -80°C, and is ready for reverse transcription (RT).  
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2.6.3 Reverse Transcription (RT) 
1-2 µg of total RNA from injected embryos was used to generate cDNA with Superscript 
II Reverse Transcriptase (Invitrogen # 18064-022) and primer p(dT)15 (Roche # 10 814 
270 001) or primer random p(dN)6 (Roche #1 034 731).  
First-Strand cDNA Synthesis  
1. The following components were added to a clean tube:  
p(dT)15 (500 µg/ml) or                                                                1 µl  
50–250 ng random primers or  
1 to 2 µg total RNA                                                                      x µl  
1 µl dNTP Mix (100 mM)                                                            1 µl 
Sterile, distilled water                                                             to 12 µl  
2. The mixture was heated to 65°C for 5 min and quickly chilled on ice. Following brief 
centrifugation, add:  
5X First-Strand Buffer                                                                 4 µl  
100 mM DTT (Promega # P117B)                                               2 µl 
RNase inhibitor (Promega # N211A)                                           1 µl  
3. The contents were gently mixed. If p(dT)15 primer was used, incubate at 42°C for 2-3 
min. If random primer was used, incubate at 25°C for 5 min.  
4. 1 µl (200 units) of SuperScriptTM II RT was added and mixed by pipetting gently up 
and down. When using random primers, incubate tubes at 25°C for 10 min.  
5. Incubate at 42°C for 90 min.  
6. Inactivate the reaction by heating at 70°C for 15 min.  
Amplification of PCR targets (>1 kb) requires the removal of RNA complementary to the 
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cDNA. To remove RNA complementary to the cDNA, 1 µl (2 units) of E. coli RNase H 
was added and incubated at 37°C for 20 min. The cDNA was then used as template for 
PCR (Tables 2.1, 2.2, 2.3, 2.4, 2.5, 2.6) or Real-Time PCR reactions (Table 2.7). 
 
Table 2.1  Primers for checking efficiency of ints5, ints9, and ints11 splice junction 
morpholinos (Figures 3.3 and 5.3) 
Primer  Sequence 
Ints5 exon1 F 5’ GAGCTTCCGGTGTCTGGTGCA 3’ 
Ints5 exon1 R 5’ GCAGCAATGCAAACTAGAACT 3’ 
Ints5 exon2 F 5’ CCCCCCCCTGCTGTATGTTTCCT 3’ 
ints5 exon2 R 5’ CGCTGGCTCCTCCACTTGCACT 3’ 
ints9 exon2 F 5’ CTGTCTGTCAGGTCATCCCA 3’ 
ints9 exon5 R 5’ CCTGTAAAGCCTGTGTGTTC 3’ 
ints11 exon9 R 5’ CTGCAGCGTTTGGAGTCTCT 3’ 
ints11 exon3 F 5’ GACTGCGGGATGCACATGGG 3’ 
 
Table 2.2  Primers to detect splicing of smad1 RNA (Figure 4.4)  
Primer  Sequence 
smad1 Exon1 F1 5’ AATCTGACGGAGTAACTGAG 3’ 
smad1 Exon1 F2 5’ GCATCAACCCTTACCACTAC 3’ 
smad1 Intron1 F 5’ GAAGCATAAAGGAGGCGACT 3’ 
smad1 Intron1 R 5’ GATAGTCTACAGAACAAACC 3’ 
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smad1 intron1 R2   5’ CAATCTATGATGCCTTCAAG 3’ 
smad1 Exon2 F 5’ ACGCTAAACTCTCCATGCTG 3’ 
smad1 Exon2 R 5’ CAGCATGGAGAGTTTAGCGT 3’ 
smad1 intron2 F  5’ GGAGTTCACCTACAGTATGT 3’ 
smad1 intron2 R   5’ CATACTGTAGGTGAACTCCT 3’ 
smad1 Exon3 R 5’ CAGTCCTGTGTCATTGGCTC 3’ 
smad1 Exon3 F1 5’ CCAGAGGAGCCAATGACACA 3’ 
smad1 Intron3 R 5’ TCAGACTGTAAGGAAGGAGC 3’ 
smad1 Exon3 F2 5’ ACTTGCCATTGGAGATCAGC 3’ 
smad1 Exon5 R1 5’ CTCAAACATTCGGCATACAC 3’ 
smad1 Intron3 F 5’ GCGTATGTGCTCTTGTGCTT 3’ 
smad1 Exon4 F1 5’ TGTTCATCCTGTGGCCTATC 3’ 
smad1 Exon5 F1 5’ GTGTATGCCGAATGTTTGAG 3’ 
smad1 Exon6 R 5’ CCTCCCTTCAACCAATCAGC 3’ 
smad1 Intron5 R1 5’ ACCTTGTGTTCATCTTGTGT 3’ 
smad1 Intron5 F1 5’ AACCATTAGACGCTGAAGTA 3’ 
smad1 Intron3 R2  5’ CAGACTGTAAGGAAGGAGCA 3’ 
smad1 Intron4 R 5’ CAGACGCGATCAATCATCAG 3’ 
smad1 Intron4 F  5’ CTGATGATTGATCGCGTCTG 3’ 
smad1 Intron5 R2  5’ CCTTGTGTTCATCTTGTGTA 3’  
smad1 Intron5 F2  5’ CCATTAGACGCTGAAGTAAA 3’ 
smad1 Exon4 R1  5’ CGATGGTTGAGTTCCGGTTG 3’ 
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Table 2.3  Primers to detect splicing of smad5 RNA (Figure 4.1) 
Primer  Sequence 
smad5 Exon1 F 5’ CTCCTTCATGTCGGTGTCTG 3’ 
smad5 Exon2 R 5’ CACTTCTCAACACCTCCCTG 3’ 
smad5 Exon2 F 5’ CAGGGAGGTGTTGAGAAGTG 3’ 
smad5 Exon3 R 5’ GGACAGGAAGTGGAAAGCAG 3’ 
smad5 Intron2-3 R 5’ GGTGCTACATAGCCAGTTAG 3’ 
smad5 Intron2-3 F 5’ GGAAAATCTATTCAACTCCC 3’ 
smad5 Exon4 R 5’ GGGTGAGTTTGGAGAGATGG 3’ 
smad5 Intron3-4 R 5’ CTGTGCACGATATGTCAGCG 3’ 
smad5 Intron3-4 F 5’ GATGTCAAGGATGCTGGATA 3’ 
smad5 Exon4 F 5’ CCATCTCTCCAAACTCACCC 3’ 
smad5 Eoxn5 R 5’ GTTCTGAGGAGCCAGGCTGC 3’ 
smad5 Intron4-5 R 5’ CTATAAGTGGTGCCTACAAG 3’ 
smad5 Intron4-5 F 5’ GGAGTTGTGAAATCTGACAC 3’ 
smad5 Eoxn5 F 5’ GCAGCCTGGCTCCTCAGAAC 3’ 
smad5 Eoxn6 R 5’ GGAGTTGCGATTGACATTAG 3’ 
smad5 Intron5-6 R 5’ CTCAACAGAGCGTGTAGGTG 3’ 
smad5 Intron5-6 F 5’ CGCTAACACCATTTGCTTGC 3’ 
smad5 Exon6 F 5’ CTAATGTCAATCGCAACTCC 3’ 
smad5 Intron6-7 R 5’ GAACACCTGTGCAACCAAGA 3’ 
smad5 Intron6-7 F 5’ CATTGGATCACAGATTAGCC 3’ 
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smad5 Eoxn7 F 5’ GTCCAGAGTCGAAACTGCAAC 3’ 
smad5 Exon8 R 5’ CAGGTCAGCCCATCATTACG 3’ 
smad5 Intron7-8 R 5’ GCTACTTTCAGCTACAAATG 3’ 
smad5 Intron7-8 F 5’ CAAGAACCAAGTGATATGAA 3’ 
 
Table 2.4  Primers to detect splicing of smad2 RNA (Figure 4.5) 
Primer  Sequence 
smad2 Exon1 F 5’ CATGTCGTCCATCTTGCCATTC 3’ 
smad2 Exon2 F 5’ CCAGAGACCCAGTTAGGAAC 3’ 
smad2 Exon5 F 5’ GTTGCCACCTTTGGACGACT 3’ 
smad2 Exon5-6 R 5’ GTGGAGGAGTTTCTGGTATG 3’ 
smad2 Exon11 R 5’ CGAGTTGTCGCTTGATGTGA 3’ 
smad2 Exon3 R 5’ GGTATCCCACTGTTCTATCG 3’ 
smad2 Exon4 R 5’ CAGACCTTTACGGTGAGACA 3’ 
smad2 Exon5 R 5’ GGAGTTGGTGTAGTCGTCCA 3’ 
smad2 Exon6 F 5’ GCCAGTGACCAGCAAATGAA 3’ 
smad2 Exon7 F 5’ GTCACCAAGCACACTCTCGC 3’  
smad2 Exon8 F 5’ CGTGGACGGCTTCACAGACC 3’ 
smad2 Exon9 F 5’ CAGAGGTATGGCTGGCATCC 3’ 
smad2 Exon10 F 5’ CAACCAGGAGTTTGCAGCAT 3’ 
 
Table 2.5  Primers to detect splicing of smad3a and smad3b RNA (Figure 4.5) 
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Primer  Sequence 
smad3a Exon1F 5’ CACAACTCAGGATGTCAACA 3’ 
smad3a Exon2R 5’ GCTGATAGTGGTAGGGATTG 3’ 
smad3a Exon2F 5’ CAATCCCTACCACTATCAGC 3’ 
smad3a Exon3F 5’ CTGGTGCCTCGACACACTGA 3’ 
smad3a Exon3R 5’ TCAGTGTGTCGAGGCACCAG 3’ 
smad3a Exon4F 5’ CAGATGAACCGGAGCATGGA 3’ 
smad3a Exon4R 5’ TCCATGCTCCGGTTCATCTG 3’ 
smad3a Exon6F 5’ CAGACCCGTCCAACTCAGAG 3’ 
smad3a Exon6R 5’ CTCTGAGTTGGACGGGTCTG 3’ 
smad3a Exon7F 5’ CGGCTGGCACCCTGCTACTG 3’ 
smad3a Exon7R 5’ CAGTAGCAGGGTGCCAGCCG 3’ 
smad3a Exon8F 5’ GTTGGCCCAGTCTGTGAATC 3’ 
smad3a Exon8R 5’ GATTCACAGACTGGGCCAAC 3’ 
smad3a Exon9R 5’ CTCTATCCAGCAGGGGGTGC 3’ 
smad3b Exon1F 5’ GAGCAGAACGGACAGGAGGA 3’ 
smad3b Exon2R 5’ CACGCTGGTAGTGATAAGGG 3’ 
smad3b Exon2F 5’ CCCTTATCACTACCAGCGTG 3’ 
smad3b Exon3F 5’ CATCCCCACAGACTTCCCTC 3’ 
smad3b Exon3R 5’ GAGGGAAGTCTGTGGGGATG 3’ 
smad3b Exon5F 5’ GTTCTCCAACGCTTTCGCCT 3’ 
smad3b Exon5R 5’ AGGCGAAAGCGTTGGAGAAC 3’ 
Chapter II                                              Materials and Methods 75 
smad3b Exon6F 5’ CTGCTCTCCAATGTCAACCG 3’ 
smad3b Exon6R 5’ CGGTTGACATTGGAGAGCAG 3’ 
smad3b Exon7F 5’ CTGTGTGTAAGATTCCTCCA 3’ 
smad3b Exon7R 5’ TGGAGGAATCTTACACACAG 3’ 
smad3b Exon8F 5’ CCCAATCAGTGAATCAGGGA 3’ 
smad3b Exon8R 5’ TCCCTGATTCACTGATTGGG 3’ 
smad3b Exon9R 5’ GAGCCCATCTGAGTGAGCAC 3’ 
 
Table 2.6  Primers to detect splicing of cyclops and squint RNA (Figure 4.6) 
Primer  Sequence 
cyc Exon1 F 5’ GCACGAGCACGCAGACACAA 3’ 
cyc Exon2 F 5’ CCAGTCTCCTACACACCGCC 3’ 
cyc Exon2 F2 5’ GAAGGAATTCGGTGCGAGGGGGCCTGCCCG 
3’ 
cyc Exon2 R 5’ CTCCGCTGCCTGAATCTGAC 3’ 
cyc Exon3 R 5’ GGAACACGACTGGGGTGATG 3’ 
cyc Exon3 R2 5’CAAGGAGCTCACAGGCATCCGCACTCCTCC
AC 3’ 
cyc Intron1 F1 5’ GTTCGCTCTCATAATCACAA 3’ 
cyc Intron1 F2 5’ GACTGTTTGGTCACAATCAC 3’ 
cyc Intron1 R1 5’ GTACCGTCAATCACTCTAAT 3’ 
cyc Intron1 R2 5’ GCGAATCCACATCGGCTTCA 3’ 
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sqt Exon1 F1 5’ CCGCTGTATATGATGCACCTC 3’ 
sqt Exon1 F2 5’ ATGATGCACCTCTACCGGACACTT 3’ 
sqt Exon2 F 5’ TGCCGAGCACTCCAAGTATG 3’ 
sqt Exon2 R1 5’ ATCCACCTCCAACTCAGACC 3’ 
sqt Exon2 R2  5’ TGAGGAGCGCAGTGATGTTGAAGA 3’ 
sqt Exon3 R  5’ CATCAAGTTATCCAGGTGCC 3’ 
sqt Intron1 F  5’ TTAATTGCTTGTCCCGAACGTGGC 3’ 
sqt Intron1 R 5’ TTGATGCCCAGGCCACTTTGAAAC 3’ 
 
2.6.4 Quantitative Real-Time PCR 
First-strand cDNA was synthesized by using Superscript II Reverse Transcriptase 
(Invitrogen # 18064-022). Semi-quantitative Real-Time PCR was performed with the 
Power SYBR Green PCR mix (Applied Biosystems # 4367659) on the 7900HT Fast 
Real-Time PCR system (Applied Biosystems http://www.appliedbiosystems.com.sg/). 
A real-time PCR reaction was set as below: 
Power SYBR Green PCR Master Mix (2X)                                                   25 µl 
Forward Primer (10 µM)                                                                               2.5 µl 
Reverse Primer (10 µM)                                                                                2.5 µl 
Template (<100ng)                                                                                           1 µl 
Distilled, sterile H2O                                                                             up to 50 µl 
Each PCR reaction was performed in triplicate, and each experiment was repeated three 
times. The PCR cycle conditions were: 95°C, 10 min, 94°C, 15sec, 60°C, 1 min, 45 
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cycles. The CT values were analyzed using the 2-∆∆T method. The primers used for real-
time PCRs are listed in Table 2.7. 
Table 2.7  Primers used in Real-Time PCRs 
Primer  Sequence 
scl F 5’ GCTGGAGATGCGGAACAGTA 3’ 
scl R 5’ GAAGGCACCGTTCACATTCT 3’ 
gata1 F 5’ CTGACCTACTGCCATCGTAT 3’ 
gata1 R 5’ GACTGAGATGAGTAGACTTG 3’ 
flk1 F 5’ CCTGGAGAACGGAACCAACA 3’ 
flk1 R 5’ CAGCCGCTTCAGCGTCTTCA 3’ 
actin F 5’ GGCTACAGCTTCACCACCA 3’ 
actin R 5’ TGCTGATCCACATCTGCTG 3’ 
U1 mature F 5’ CTTACCTGGCAGGGGAGACA 3’ 
U1 mature R 5’ GCAGTCGAGATTCCCACATT3’ 
U1 primary F 5’ GACACCATGATCAGGAAGGT 3’ 
U1 primary R 5’ CTATTTTGACCATGTGATC 3’ 
U2 mature F 5’ GGCTAAGATCAAGTGTAGTATC 3’ 
U2 mature R 5’ AGCAAGCTCCTATTCCAACTCC 3’ 
U2 primary F 5’ CAAGTGTAGTATCTGTTCTTATC 3’ 
U2 primary R 5’ TTTACCAGGTTAGGGGGTGCAC 3’ 
18s rRNA F 5’ GAGAAACGGCTACCACATCC 3’ 
18s rRNA R 5’ GGACACTCAGCTAAGAGCATCG 3’ 
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2.7 MAY-GRUNWALD GIEMSA STAINING 
2.7.1 Cytospin 
200 µl of blood cells were extracted in Tricaine buffer (0.02% Tricaine/PBS with 1% 
BSA) from approximately 20 fishes by clipping their tails.  
Before cytospining, 200 µl of Tricaine buffer was loaded into the cytofunnel for 
normalization. After loading, the samples were spun at 400 rpm for 3 min (Shandon 
Cytospin 4). The blood cells will be concentrated in the circular area of the cytospin glass 
slides. The slides were air-dried and subjected to May-Grunwald Giemsa staining (Qian 
et al., 2007). 
2.7.2 Giemsa Staining 
After cytospining, 1 ml of May-Grunwald eosin methylene blue stain solution (May-
Grunwald solution:methanol = 1:3, Merck # 1.01424.0100) was gently added to cover the 
cytospin area and leave for 1min before running off the solution completely. Then 1 ml of 
Giemasa stain solution (freshly prepared; Giemsa solution:Phosphate buffer = 1:20, 
Merck #1.09204.0500) was added onto the cytospin area and rocked gently for 15-30 
min. After runing off the solution with slow running water, slides were left at room 
temperature to air-dry (Qian et al., 2007). 
Phosphate buffer (every 1000 ml):  
KH2PO4 6.63 g 
Na2HPO4 2.56 g 
Adjust the pH value to 6.4 and filter before use. 
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2.8 WESTERN BLOTTING  
To reduce the background, the yolk of embryos was removed using needles under a 
dissecting microscope. Cells from 20 embryos were collected into a tube and excess egg 
water was removed by pipetting. 20 µl of 1 x SDS loading buffer was added to the 
embryos and the mixture was vortexed vigorously, and boiled for 5 min. Then the sample 
was analyzed on a protein electrophoresis gel in 1 x SDS running buffer. Protein was 
transferred to a nitrocellulose membrane (Amersham Biosciences #RPN203E). The 
membrane was blocked in 5% milk blocking buffer for 2 h at RT or at 4°C overnight with 
slight rocking.    
Ints5 protein was detected using rabbit anti-Ints5 antibody (1:500, Bethyl Laboratories 
A301-268A). Smad5 protein was detected using rabbit anti-Smad5 polyclonal antibody 
(1:500, Abcam ab13724). The expression of α-tubulin control was detected using mouse 
anti-α-tubulin monoclonal antibodies (1:1000, Sigma #T5293). Anti-mouse 
immunoglobulins (1:5000, DAKO #P0260) or anti-rabbit immunoglobulin (1:5000, 
DAKO #P0448) were used as secondary antibodies and detected by SuperSignal West 
Femto Maximum Sensitivity Substrate (Pierce #34095) or by SuperSignal West Pico 
Chemiluminescent Substrate (Pierce #34077). 
 
2.9 MICROSCOPY 
All the images were taken under the Zeiss Axioplan 2 Imaging System. 
The DIC images for live embryos were taken under 10X/0.3 objective, using 
Photometrics Coolsnap HQ monochrome camera and MetaMorph software (Universal 
Imaging Corporation). 
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The bright-field images for red blood cells with Giemsa staining and in situ embryos 
were taken under 63X/1.4 oil and 10X/0.3 objectives, respectively, using Nikon DXM 
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3.1 BACKGROUND 
The C-terminal domain (CTD) of RNA polymerase II (RNAPII) is not only essential for 
transcription of protein-coding genes. A large body of data also implicates CTD in the 
transcription and processing of RNAPII-mediated small nuclear RNAs (snRNAs) (Egloff 
and Murphy, 2008; Egloff et al., 2007; Egloff et al., 2008; Uguen and Murphy, 2003). 
However, the identity of the protein (or complex) that associates with the CTD and 
mediates specific processing of snRNAs has remained elusive. Baillat et al. described an 
RNA polymerase II associated complex that contains at least 12 novel subunits, termed 
the Integrator (Int). Two of the Integrator subunits (Ints), Ints9 and Ints11 display 
similarities to the subunits of the cleavage and polyadenylation specificity factor (CPSF) 
complex (Baillat et al., 2005). 
Baillat et al. also showed that the Integrator complex directly interacts with the C-
terminal domain of the RNA polymerase II largest subunit and is recruited to the U1 and 
U2 snRNA genes where it mediates 3’end processing of the snRNA (Baillat et al., 2005). 
 
3.2 IDENTIFICATION OF INTEGRATOR SUBUNITS 
The Integrator complex is conserved in metazoans (Baillat et al., 2005). To study the 
function of these novel genes during embryogenesis, we have cloned several subunits of 
Integrator complex in zebrafish: Ints3, Ints5, Ints6, Ints7, Ints9, Ints10, Ints11, Ints12 
(Table 3.1, Figure 3.1). The genomic locus of ints5 has several gaps in the sequence 
assembly, so RACE (Rapid Amplification of cDNA Ends) was performed for cloning of 
ints5, whereas other genes were cloned into pCS2+ vector by PCR with primers designed 
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according to Ensembl sequence (Table 3.1, Section 2.2.1). It has been recently found that 
depletion of Integrator subunit 5 (Ints5) in the Drosophila germarium affects 
Decapentaplegic (Dpp, the homologue of vertebrate BMP) signaling activities, which in 
turn leads to failure in oogenesis (Cai et al., unpublished data). It is possible that the 
Integrator complex is required for proper BMP function during vertebrate development as 
well, so I got interested in studying the function of Integrator subunits, especially Ints5, 
and elucidating the link between Ints5 and BMP signaling during early development of 
zebrafish. Therefore, I focused on the function of Ints5 in zebrafish. 
Zebrafish Ints5 shares about 53% similarity with its human orthologue and there is no 
known functional domain in the peptide sequence (Figure 3.1).  











Ints2 KIAA1287, INT2 81% ENSDARG0000007682
3 
Ints3 si:dkey-27c15.2, INT3 83% ENSDARG0000001681
1 




Ints5 KIAA1698, LOC564642, INT5 53% ENSDARG0000007718
9 
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Ints6 ddx26b, INT6 67% ENSDARG0000001793
1 




Ints8 C8orf52, FLJ20530, MGC131633, 
Kaonashi-1, zgc:111823, INT8 
69% ENSDARG0000005798
6 
Ints9 cpsf3, INT9 87% ENSDARG0000002764
9 
Ints10 wu:fb96d03, wu:fi39h05, 
zgc:111853, zgc:136485, INT10 
67% ENSDARG0000004303
1 
Ints11 zgc:110671, INT11 81% ENSDARG0000002521
2 
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Figure 3.1 Ints5 is evolutionarily conserved. (A) The phylogenetic tree of Ints5. (B) 
Full cDNA sequence of zebrafish ints5. The translation start site is shown in yellow, 
splice site in red. The sequence of 5’and 3’ UTRs is in light blue. (C) Peptide sequence of 
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3.3 THE EXPRESSION OF INTS5 TRANSCRIPTS 
We choose to study the function of Integrator subunit 5 during zebrafish embryogenesis. 
Whole Mount In Situ Hybridization (WISH) with labeled anti-sense RNA probes shows 
that ints5 transcript is expressed both maternally and zygotically (Figure 3.2). As shown 
in figure 3.2, ints5 transcripts can be detected immediately after fertilization, in the whole 
blastodisc of a one-cell stage embryo (Figure 3.2A), preceding the onset of zygotic 
transcription at mid-blastula transition (MBT). The distribution of ints5 transcript is 
ubiquitous during cleavage and gastrulation stages (Figure 3.2B, C). During 
somitogenesis (Figure 3.2D), ints5 transcripts persist, with expression noticeably stronger 
in the anterior region of the embryo. In contrast, WISH with control sense RNA probes 
does not show any staining in the embryos at comparable stages (Figure 3.2E-H). The 
presence of maternal and zygotic ints5 transcripts at various stages was further confirmed 
by RT-PCR, using oligo dT-primed cDNA templates (indicated by 150 bp fragments in 
Figure 3.2I).  
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Figure 3.2 Ints5 is expressed both maternally and zygotically in zebrafish embryos. 
(A-D) Whole mount in situ hybridization to detect ints5 expression in wild type (WT) 
embryos at various stages. (E-H) WT embryos hybridized with control ints5 sense strand 
probe. (A, C-E, G, H) Lateral views of embryos. (B, F) animal pole views. (I)  RT-PCR 
shows ints5 RNA expression at various embryonic stages. Scale bars in (A, C) 50µm, in 
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3.4 KNOCK-DOWN OF INTS5 BY ANTI-SENSE MORPHOLINOS 
The ints5 locus consists of two exons and one 2.6kb intron. To investigate the function of 
Ints5 during early zebrafish development, I knocked down Ints5 function using anti-sense 
morpholinos. Two anti-sense splice-junction morpholinos were designed to target the 
intronic splice donor and acceptor sites of the ints5 transcirpts (Figure 3.3A). In ints5 
morphants, reverse transcription–PCR (RT-PCR) analysis with primer pair 1 and 4 shows 
the presence of aberrantly spliced ints5 transcripts (Figure 3.3B). PCR with primer pairs 
1 and 3 and 2 and 4 also shows accumulation of non-spliced ints5 transcripts in embryos 
injected with ints5 splice-junction morpholinos (Figure 3.3B). Sequence analysis of the 
PCR products indicates that in the morphants, the correct exon/intron boundary is not 
chosen and instead, a cryptic site in exon1 of ints5 transcript is used. This leads to the 
production of incorrectly spliced ints5 transcripts lacking 170 bp of the coding sequence 
(Figure 3.3C). Therefore, the splice-junction morpholinos indeed disrupt the correct 
processing of ints5 transcripts. 
Western blot analysis using antibodies to detect Int5 protein (110 kDa) in embryo 
extracts shows that the ints5 morpholinos abolish the synthesis of Ints5 proteins, whereas 
injection of ints5 RNA leads to high Ints5 protein levels in injected embryos (Figure 3.4). 
The expression of control α-tubulin protein is not altered in the same embryo extracts 
(Figure 3.4).  
By 24 hours post fertilization (hpf), embryos injected with ints5 splice-junction 
morpholinos show severe defects, with a shortened anterior-posterior axis and no 
circulating blood cells (Figures 3.5B, 3.9J), in contrast to control morpholino injected 
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embryos (Figure 3.5A).  These phenotypes are rescued by co-injecting ints5 RNA with 
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Figure 3.3 Knockdown of ints5 with anti-sense splice morpholinos. 
(A) Schematic representation of the ints5 genomic locus. Two orange bars indicate target 
sites of the donor and acceptor morpholinos. Numbered black arrows show the position 
of primers used in RT-PCRs (B) to examine whether the splicing of ints5 RNA has been 
disrupted. (B) RT-PCRs to detect splicing of ints5 and control β-actin RNA from sphere 
stage (4 hours post fertilization, 4 hpf) embryos injected with control or ints5 donor and 
acceptor morpholinos at one-cell stage. (C) Schematic representation of the correctly 
spliced (upper) and aberrantly spliced (lower) ints5 transcripts. The sizes of the fragments 
amplified by primer pair 1 and 4 are indicated on the right. The red open arrowhead 
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Figure 3.4 Ints5 morpholinos abolish Ints5 protein in embryos.  
Western blots on extracts of embryos injected with lacZ RNA, ints5 RNA or ints5 
morpholinos. Proteins of each sample were harvested from 20 injected embryos at 8 hpf.  
Ints5 proteins were detected by using rabbit anti-Ints5 antibody (Bethyl Laboratories) 
(upper panel); the lower panel shows expression of α-tubulin control detected using anti-
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Figure 3.5 Knockdown of ints5 leads to abnormal development of zebrafish 
embryos. 
(A-C) DIC images of live embryos injected with control morpholinos (A), ints5 acceptor 
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3.5 ANALYSIS OF GERM LAYER GENE EXPRESSION IN INTS5 
MORPHANT EMBRYOS.  
Although live embryos injected with ints5 splice-junction morpholinos look stubby 
(Figure 3.5B), their general dorso-ventral axis formation seems normal. To further 
examine the effect of knocking-down inst5 on dorso-ventral axis and germ layer 
specification, we applied WISH with various markers on morpholino-injected embryos at 
different gastrula stages (Figures 3.6, 3.7). 
3.5.1 Expression Of Dorsal-Ventral Markers In ints5 Morphant Embryos 
In lower vertebrate, maternally deposited determinants lead to the establishment of the 
dorsal axis and the organizer. One of the essential organizer factors is Nodal. Nodal 
related proteins serve as mesoderm and endoderm inducers. The organizer seems to 
pattern the dorsal cell fate primarily by opposing morphogenetic activities of BMPs from 
the ventro–lateral regions of the embryo. There are a number of molecular markers 
involved in this event, such as, goosecoid (gsc) and chordin (chd) on the dorsal side and 
even-skipped 1(eve1) on the ventral side (De Robertis et al., 2001; Joly et al., 1993; 
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Figure 3.6 Knock-down of ints5 does not affect dorso-ventral patterning.  
(A-H) Whole mount in situ hybridization to detect expression of goosecoid (gsc) (A, B), 
even-skipped 1 (eve1) (C, D) chordin (E-H), at sheild (6 hpf) or 50% epiboly (5.3 hpf) 
stage. Embryos are injected with control (A, C, E, G) or ints5 morpholinos (B, D, F, H). 
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Figure 3.7 Knockdown of ints5 does not affect germ-layer specification.  
(A-J) Whole mount in situ hybridization to detect expression of no tail (ntl) (A-D) and 
spadetail (spt) (E, F), at 50% epiboly (5.3 hpf), and 75% epiboly (8 hpf) respectively. 
Embryos are injected with ints5 morpholinos (B, D, F), or control morpholinos (A, C, E). 
Open arrowheads in (E, F) indicate the distance between spt positive cells in the midline. 
The red arrow indicates the head mesoderm. (G-J) Expression of dlx3 (G, H) in the neural 
plate boundary at tailbud stage (TB, 10 hpf), and sox17 (I, J) in the endoderm of 75% 
epiboly embryos injected with ints5 morpholinos (H, J) or control morpholinos (G, I). 
Black arrows in G, H mark the distance between the boundary of dlx3 expression. (A, B) 
lateral view of embryos with animal pole to the top; (C, D) animal pole view. (E-J) dorsal 
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goosecoid (gsc), homeobox-containing gene, is a direct target of Nodal signaling pathway 
which induces dorsal cell fates (Toyama et al., 1995). gsc transcripts accumulate after the 
midblastula transition at the margin of the blastoderm. Its expression increases during the 
beginning of epiboly, and at the onset of gastrulation, gsc transcripts are observed in the 
deep cell layer of the margin. As gastrulation begins, all gsc-expressing cells invaginate 
and form the central part of the embryonic shield (Figure 3.6A). After 70% epiboly, these 
cells will become the leading edge of the mesendoderm, the prechordal plate (Thisse et 
al., 1994). Chordin is secreted by dorsal organizer and functions as a BMP antagonist, 
and its expression is restricted at the dorsal side of the embryo (Figure 3.6E, G) (Wagner 
and Mullins, 2002). The homeobox gene zebrafish eve1 is a member of even-skipped 
(eve) gene family. During gastrulation, eve1 transcripts are confined to ventral and lateral 
cells of the marginal zone of the embryo (Figure 3.6C). Later, eve1 is expressed in the 
most posterior part of the tail bud during somitogenesis. In LiCl-treated dorsalized 
embryos, eve1 transcripts are completely absent, suggesting that eve1 marks the 
specification of ventral mesoderm in zebrafish gastrulae (Joly et al., 1993). 
As zebrafish embryos with mutations in a number of genes that affect dorso-ventral 
patterning usually have altered gsc, chordin, eve1 expression (Joly et al., 1993; Miller-
Bertoglio et al., 1997; Stachel et al., 1993; Thisse et al., 1994; Wagner and Mullins, 
2002), we examined expression of these genes in ints5 morphants at mid-gastrulation 
stages. In ints5 morpholino injected embryos, expression of gsc (Figure 3.6B), chordin 
(Figure 3.6F, H) and eve1 (Figure 3.6D) is normal and not altered in either expression 
level or distribution, similar to that of control morpholino injected embryos (Figure 3.6A, 
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C, E, G). Thus, the early dorso-ventral patterning is not perturbed by knocking-down 
ints5. 
3.5.2 Expression Of Germ Layer Markers In ints5 Morphant Embryos 
I also examined the patterning of the three germ layers by monitoring the expression of 
no tail (ntl) and spadetail (spt) in mesoderm, distal less 3 (dlx3) in ectoderm and sox17 in 
endoderm of the embryos (Figure 3.7). 
For mesoderm development in the mouse, the T or Brachyury gene is crucial. Embryos 
homozygous for the mutation T fail to produce sufficient mesoderm and lack all posterior 
structures. Most strikingly, they lack the entire notochord (Gluecksohn-Schoenheimer, 
1944; Yanagisawa et al., 1981). Similarly, in zebrafish, expression of the T-box gene ntl 
is first detected at dome stage in a restricted ring-like area, the marginal zone of the 
blastoderm (Schulte-Merker et al., 1992). In concert with movements of convergence and 
extension, ntl expression domain converges towards the midline and extends along the 
embryonic axis. By the end of gastrulation, ntl expression occurs in the midline axis 
which later will give rise to the presumptive notochord (Schulte-Merker et al., 1992).  
Another T-box transcription factor gene, spt, is required for non-notochordal trunk 
mesoderm formation. Homozygous spt mutant embryos have major trunk mesoderm 
deficiencies, but relatively normal tail and notochord development. Trunk and tail 
development are therefore dependent upon the complementary actions of two T-box 
genes, spadetail and no tail (Griffin et al., 1998). Expression of spt is first detected 
between sphere and dome stages where it is initially ubiquitous. By early gastrula stage, 
spt expression becomes rapidly restricted to marginal cells (Griffin et al., 1998). After 
shield stage, spt is not expressed in the notochord progenitors, whereas lateral and ventral 
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germ ring and head mesoderm (red arrow) express spt (Figure 3.7E). 
In ints5 morpholino injected embryos, expression of ntl (Figure 3.7B, D) and spt (Figure 
3.7F) is normal, and staining is not altered in intensity or extent, similar to that of control 
morpholino injected embryos (Figure 3.7A, C, E). However, there is a wider gap (open 
arrow heads in Figure 3.7E, F) in the spt expression in the midline. This may indicate 
defective cell movements towards the dorsal (convergence). The patterning of mesoderm 
per se is not disturbed by knocking-down ints5.  
For the proper development of ectoderm in Xenopus and mouse, a homeodomain 
transcription activator Distal less 3 (Dlx3) plays important roles (Beanan and Sargent, 
2000). In zebrafish, dlx3 transcription begins during gastrulation, defining a narrow band 
of cells at the lateral boundary of the presumptive neural plate (Akimenko et al., 1994). In 
ints5 morpholino injected embryos, expression pattern of dlx3 (Figure 3.7H) is generally 
normal and comparable to control embryos (Figure 3.7G). Although, the specification of 
ectoderm is not disturbed by knocking-down of ints5, the distance between the 
boundaries of dlx3 expressing cells become much larger in ints5 morphant at the end of 
gastrulation (indicated by black arrows in Figure 3.7G, H). This phenotype once again 
shows the impaired convergence-extension cell movement induced by knocking-down of 
ints5.  
Similarly, the patterning of endoderm was examined based upon the expression of the 
endoermal marker gene sox17. Zebrafish Sox17 protein is highly related to mouse Sox17 
and Xenopus Xsox17a and Xsox17b, which are important intrinsic regulators of 
endoderm formation and contain a high motility group (HMG) DNA binding domain 
(Alexander and Stainier, 1999; Hudson et al., 1997; Kanai et al., 1996). sox17 is first 
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detected in the non-involuting forerunner cells at the onset of gastrulation. Soon 
thereafter, sox17 is expressed in the endodermal precursors and this expression continues 
throughout gastrulation. At 75% epiboly, sox17 expression in ints5 morphant is almost 
the same as in control embryos (Figure 3.7I, J). This suggests that the specification of 
endoderm is not affected in embryos injected with ints5 morpholinos. 
In summary, the patterning of three germ layers: mesoderm, ectoderm and endoderm is 
unaffected when ints5 is knocked-down in zebrafish embryo. Furthermore, the expression 
of different markers also indicates that the anterior-posterior axis is largely normal. 
 
3.6 CONVERGENT-EXTENSION CELL MOVEMENTS ARE 
IMPAIRED IN INTS5 MORPHANTS 
At 24 hpf, embryos injected with ints5 splice-junction morpholinos show shortened body 
axis (Figure 3.5B) and in gastrulating embryos, the distance between the boundaries of 
spt or dlx3 positive cell are enlarged (Figure 3.7F, H), in comparison to control 
morpholino injected embryos (Figures 3.5A, 3.7E, G).  These phenotypes indicate 
multiple defects in convergent-extension (CE) cell movements during gastrulation. To 
characterize the CE movement defects, I performed bi-color WISH to monitor the 
expression of hgg1, ntl and dlx3. The hgg1-expressing cells are the most anterior 
migrating mesendoerm cells, which will later give rise to the hatching gland. The 
expression of ntl marks the migrating mesendoderm cells in the midline and dlx3 
expression marks the boundary of the neural plate (Akimenko et al., 1994; Schulte-
Merker et al., 1992; Thisse et al., 1994). 
We observed retarded convergence, marked by the increased distance between dlx3 
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positive cells at the dorsal side, and impaired anterior extension marked by position of 
hgg1 positive cells (Figure 3.8B, C) and anterior limit of ntl expressing cells in more than 
80% embryos (Figure 3.8E, F, H, I). Some embryos (Class II) show more severe 
convergent-extension defects than others (Class I), referring to the bigger distance 
between dlx3 positive cells (marked by dashed lines) and larger gap between animal pole 
and the anterior limit of ntl expression (marked by black arrowheads). These cell 
movement defects can be rescued by co-injecting ints5 RNA, where over-expression of 
ints5 RNA itself into wild type embryos does not cause CE defects (Figure 3.8 J). Since 
the expression of different germ layer markers suggests that anterior-posterior patterning 
is largely normal (Figures 3.6 and 3.7), the shortened axis in ints5 morphant embryos is 
likely due to impaired CE cell movements. Therefore, Ints5 is required for proper 
convergent-extension cell movements during gastrulation. 
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Figure 3.8 Knockdown of ints5 leads to convergent-extension defects during 
gastrulation.  
 (A-I) Whole mount in situ hybridization to detect ntl, dlx3 and hgg1 expression in 
tailbud (TB, 10 hpf) embryos injected with control morpholinos (A, D, G), ints5 
morpholinos (B, C, E, F, H, I). Black arrowheads indicate the anterior limit of ntl 
expression in the midline, and red arrows indictae hgg1 staining in the anterior prechordal 
plate mesendoderm cells. White arrowheads and dotted lines indicate the distance 
between the lateral limits of dlx3 expression in the neuroectoderm. (A-C) animal pole 
views of embryos, (D-F) dorsal views of embryos, (G-I) lateral views of embryos with 
dorsal to the right. 
 (M) Histogram showing percentage of injected embryos with wildtype (WT, blue) or 
impaired (magenta, Class I and yellow, Class II) cell movement marked by ntl/dlx3/hgg1 
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3.7 KNOCK-DOWN OF INTS5 LEADS TO DEFECTIVE 
HEMATOPOIESIS.  
Since live ints5 morphant embryos at 24 hpf lack circulating blood, we did two different 
types of analyses to check whether hematopoiesis is affected by the knock-down of ints5. 
3.7.1 Ints5 Is Required For Proper Expression Of Hematopoietic Genes. 
First, we examined the expression of the hematopoietic genes stem cell leukemia (scl) and 
gata1 by WISH (Detrich et al., 1995; Gering et al., 1998). Expression of scl transcripts is 
severely reduced in ints5 morphants (Figures 3.9C, D, 3.11B) in comparison to control 
morphants (Figures 3.9 A, B, 3.11A). In contrast, the adjacent pax2a expressing 
pronephric cells are not affected in ints5 morphants (Figure 3.11 A, B) (Majumdar et al., 
2000). 
ints5 morpholino injected embryos have impaired cell movement, and usually grow 
slower during gastrulation and somitogenesis. To rule out the possibility that their 
delayed development account for the reduced scl expression, we fixed both control and 
ints5 morpholino injected embryos at the same stage, 6-somite stage and performed bi-
color WISH with scl and myoD on the stage-matched embryos (Weinberg et al., 1996). 
The anterior limit of scl expression aligns with the anterior somite (marked by myoD) in 
controls (Figure 3.11C), whereas in ints5 morphants, the anterior limit of major scl 
expression domain aligns with the most posterior somite (Figure 3.11D). Thus, the 
defects seen in the ints5 morphants are not due to developmental delay, but rather due to 
a lack of the anterior scl expression domain. 
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Figure 3.9 Knockdown of ints5 leads to reduced expression of hematopoitic genes. 
Whole mount in situ hybridization to detect expression of scl (A-H) at 12 hpf and gata1 
(I-K) at 26 hpf in ints5 morphants (C, D, J), and control morpholino (A, B) or lacZ RNA  
(I) injected embryos. Co-injection of Ints5 RNA can restore scl and gata1 expression in 
ints5 morphants (G, H, K), whereas embryos injected with ints5 RNA alone show normal 
scl expression at 12 hpf (E, F). The black arrowheads indicate the anterior limit of scl 
expression in the intermediate cell mass (ICM), the open arrowheads indicate scl 
expression in rostral blood island (RBI) and black arrows indicate anterior gata1 
expression, which represents the circulating blood cells. (A, C, E, G) show dorsal views 
of embryos with the anterior to the top. (B, D, F, H) show lateral views of embryos. (I-K) 
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Figure 3.10 Ints5 regulates hematopoietic gene expression.  
Histograms to show expression level of scl (A), and gata1 (B) in injected embryos.  
Expression levels were measured at 12 hpf by semi-quantitative RT-PCR, normalized 
with respect to the level of β-actin internal control, and shown as fold-change relative to 
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Figure 3.11 Ints5 knock-down affects hematopoietic progenitors but not pronephric 
and myotome cells.  
Double in situ hybridization to detect expression of scl (purple) in hematopoietic cells 
(A-D), pax2a (red) in the pronephric cells (A, B, 16 hpf) and myoD (red) in myotome 
cells (C, D, 12 hpf or 6-somite stage). The black arrowheads indicate the anterior scl 
expression in the ICM, and its reduction in ints5 morphants. (A-D) show flat-mounted 
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Expression of gata1, which is critical for specification of erythrocytes (Orkin and Zon, 
1997), is also reduced in ints5 morphants (Figure 3.9J).The reduction of scl and gata1 
can be rescued by co-injecting ints5 RNA (Figure 3.9G, H, K), whereas over-expression 
of ints5 RNA by itself does not affect scl expression (Figure 3.9E, F).   
To confirm the above results, semi-quantitative real-time PCR was performed to examine 
the expression levels of scl and gata1 genes (relative to β-actin). The expression levels of 
scl and gata1 are decreased to 50% and 37% of normal levels, respectively, in ints5 
morphants. Co-injection of ints5 RNA with ints5 morpholinos can restore the expression 
of scl and gata1 to normal levels (Figure 3.10). 
Together, the above experiments show that Ints5 function is required for proper 
expression of hematopoietic genes. 
As scl expression is also critical for the formation of vascular precursors, we examined 
the expression of endothelial gene, flk1, at various stages (de Jong and Zon, 2005; Liao et 
al., 1997). We find that although early expression of flk1 is reduced in ints5 morphants 
(Figure 3.12A, B), it seems to recover later (at 15 hpf, Figure 3.12C, D), and by 24 hpf, 
flk1 experssion is detected in most domains observed in control embryos (Figure 3.12E, 
F). Expression of flk1 seems reduced in inter-segmental vessels, but this may reflect cell 
migration and/or vessel branching defects. These results suggest that the common 
progenitor of hematopoietic and endothelial cells, the hemangioblast precursors (Vogeli 
et al., 2006) per se are not affected in ints5 morphants, and that Ints5 function is 
specifically required for hematopoietic development. 
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Figure 3.12 Ints5 knockdown does not affect endothelia cells.  
(A-H) Whole mount in situ hybridization to detect expression of flk1 (purple) in 
endothelial cells at 12 hpf (A, B), 15 hpf (C, D) and 24 hpf (E-H). Red arrowheads in (A, 
B) indicate flk1 expression. The insets show magnified views of the areas in black box. 
Inter-segmental flk1 expression is not detected in ints5 morphant (F), in comparison to 
control embryos (E) and ints5 RNA injected embryos (G). Expression of flk1 in inter-
segmental vessels is rescued by co-injection of ints5 RNA (H). (A, B) show dorsal views 
of flat mounted embryos. (C, D) show dorsal views with anterior to the left. (E-H) show 
lateral views of the trunk with anterior to the left. Scale bars in (A, C), 100µm, in (E, 
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3.7.2 Ints5 Is Required For Erythrocyte Differentiation. 
A previous study by Qian et al., 2007 showed that scl isoforms function in initiation of 
primitive hematopoiesis and regulate erythroid cell differentiation. Since ints5 
morpholino-injected embryos have reduced scl expression, we examined erythroid 
differentiation in Ints5-manipulated embryos (Qian et al., 2007).  
May-Grunwald Giemsa staining of blood smears from wild type embryos shows normal 
erythrocyte progenitors. These cells differentiate and are typically categorized as: stage I, 
basophilic erythroblast (30 hpf); stage II, polychromatophilic erythroblast (2 days post 
fertilization, 2 dpf); stage III, orthochromatophilic erythroblast (4 dpf); stage IV, 
erythrocyte (5 dpf onwards) (Figure 3.13A-C). The categorization is based on the shape 
of their nucleus, size and morphology of the cells, and staining of the cytoplasm (Qian et 
al., 2007).  
Blood smear analysis shows that whereas 98% of RBCs (n=589) grow to the 
polychromatophilic erythroblast stage (stage II) in control embryos by 2 dpf (Figure 
3.13D, J), only 58% (n=517) of RBCs in ints5 morphants develop normally. In ints5 
morphant embryos, 42% (n=517) of cells arrest at the basophilic erythroblast stage (stage 
I) (Figure 3.13E, J).  
To investigate the role of Ints5 in RBC differentiation, we reduced the dosage of the anti-
sense morpholinos (ints5 morpholinos donor+acceptor, 1ng+1ng/embryo) so as to allow 
embryos to survive till later stages, as embryos injected with normal dose of ints5 
morpholinos usually die by 3 dpf.  At 7 dpf, only 30% (n=240) of RBCs in ints5 
morphant embryos injected with the low dose of morpholinos differentiate normally in 
comparison to control embryos where ~80% (n=265) of the cells are fully-developed, 
Chapter III                             The Functional Analysis of Ints5 121 
mature RBCs with flattened elliptical shape (Figure 3.13G, H, K).  
Normal differentiation of RBCs in ints5 morphants was restored by co-injection of ints5 
RNA (Figure 3.13F, I, J, K, 2 dpf n=753, 7 dpf n=209) at both stages.  Thus, Ints5 
function is required for the normal differentiation of erythrocytes. 
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Figure 3.13 Ints5 is required for erythrocyte differentiation.  
(A-C) May-Grunwald Giemsa staining shows normal RBCs at various stages.  (D-F) 
RBCs in embryos injected with control morpholinos (D), ints5 morpholinos (E), or co-
injected with ints5 RNA and morpholinos (F), respectively, at 2 dpf.  The arrows indicate 
the RBCs arrested at basophilic erythroblast stage (E). (G-I) RBCs in embryos injected 
with control morpholinos (G), ints5 morpholinos (H), or co-injected with ints5 RNA and 
morpholinos (I) respectively at 7 dpf. (J, K) Histograms showing percentage of RBCs 
with normal (blue) or arrested (magenta) differentiation in injected embryos at 2 dpf (J) 
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4.1 INTS5 IS IMPORTANT FOR PROPER SPLICING OF SMAD1 AND 
SMAD5 TRANSCRIPTS 
The Integrator complex is evolutionarily conserved in metazoans and directly interacts 
with the C-terminal domain of RNA polymerase II largest subunit. It is recruited to the 
U1 and U2 snRNA genes and mediates snRNA 3’ end processing (Baillat et al., 2005). 
U1 and U2, together with U4, U5, and U6 small nuclear RNAs, are involved in the major 
form of pre-mRNA splicing. Each is in a complex of at least seven protein subunits to 
form an snRNP (small nuclear ribonucleoprotein). These snRNPs form the core of the 
spliceosome, a large assembly of RNA and protein molecules that performs pre-mRNA 
splicing in the cell (Alberts et al., 2002). Therefore, knockdown of ints5 is likely to affect 
the splicing of target genes. 
As Cai Yu’s work implied that Ints5 may be required for proper DPP/BMP signaling 
during Drosophila development, and ints5 morpholino-injected zebrafish embryos have 
decreased scl expression, similar to embryos with mutation in zebrafish smad5, (a 
transcription factor that mediates BMP signaling) (McReynolds et al., 2007), we 
investigated whether the splicing of smad5 and its highly related orthologue smad1 is 
disrupted in ints5 morphant embryos. Splicing of smad2, smad3a, smad3b, cyclops, 
squint and β-actin RNAs was also examined as controls. Total RNA was extracted from 
embryos injected with control or ints5 splice morpholinos, and RT-PCR was performed 
with primers for the various genes (Table 2.1-2.6). We found that, the splicing of smad5 
and smad1 transcripts is impaired, whereas the transcripts for all other examined genes 
are correctly spliced. 
As early as sphere and 30% epiboly stages, aberrantly spliced smad5 transcripts 
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accumulate in ints5 donor morpholino (DM) and acceptor mopholino (AM) injected 
embryos. In contrast, β-actin control transcripts are correctly spliced to yield a 500 bp 
product from cDNA in comparison to a 700 bp genomic (G) DNA product (Figure 4.1A, 
B). Figure 4.1C shows the schematic representation of wild type (710 bp) and aberrant 
smad5 transcripts that lack exon 4 (466 bp product), or lack both exon 4 and exon 5 (350 
bp) (Figure 4.1C).  
To test the activity of the aberrant smad5 splice products, we injected capped synthetic 
smad5 RNAs, lacking exon 4 (smad5∆exon4), or exons 4 and 5 (smad5∆exon4, 5) into 
one-cell stage zebrafish embryos. Analysis of scl expression at 12 hpf shows that 
embryos injected with smad5∆exon4 or smad5∆exon4, 5 RNA have reduced expression 
in a dose dependent manner at 12 hpf. The phenotype is similar to that of ints5 morphants 
(Figures 3.9C, D, 4.2B, C, E-G). So it is possible that ints5 morpholino induced aberrant 
smad5 transcripts can be translated into truncated forms, which may function as 
dominant-negative Smad5 during development. 
To confirm the possibility, I examined the presence of truncated Smad5 by western blot 
analysis.  Using antibodies to detect Smad5 protein in embryo extracts, I detected less full 
length Smad5 (52KDa), as well as truncated forms of Smad5, corresponding to the 
aberrant transcripts smad5∆exon4 (43KDa) and smad5∆exon4, 5 RNA (39KDa) (Figure 
4.3). This result confirms that the ints5 morpholinos indeed abrogate the production of 
Smad5 proteins, and lead to the production of truncated Smad5 that have the potential to 
function as dominant-negative proteins.  
 
















Chapter IV   Ints5 Functions in Hematopoiesis by Regulating Smad1/Smad5 Splicing 128 
Figure 4.1 Knock-down of Ints5 perturbs splicing of smad5 RNA.  
(A)Schematic representation of the smad5 genomic locus.  Numbered black arrows 
indicate the position of primers used in RT-PCRs to detect splicing. The sizes of the 
predicted products are indicated on the right. (B) At both sphere and 30% epiboly stages, 
aberrantly spliced smad5 transcripts accumulate in ints5 donor morpholino (DM) and 
acceptor mopholino (AM) injected embryos. Splicing of β-actin control is unaffected. (C) 
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Figure 4.2 Over-expression of truncated smad5 transcripts causes hematopoiesis 
defects, similar to ints5 morphants.  
(A-F) The whole mount in situ hybridization to detect scl in control embryos (A, D), 
embryos injected with smad5∆E4 RNA (B, E) or smad5∆E4, 5 RNA (C, F) at 12 hpf.  
The black arrowheads indicate the anterior limit of scl expression in the ICM. The open 
arrowheads mark scl expression in RBI. Upper panel shows dorsal views with the 
anterior to the top; Lower panel shows lateral views with dorsal to the right. (G) 
Histogram showing percentage of injected embryos with wild type like (blue) or reduced 
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Figure 4.3 Ints5 knockdown leads to production of truncated Smad5 protein in 
embryos.  
Western blots on extracts of embryos injected with control and ints5 morpholinos. 
Proteins of each sample were harvested from 20 injected embryos at 8 hpf. Smad5 
proteins were detected by using rabbit anti-Smad5 polyclonal antibody (Abcam) (upper 
panel); the lower panel shows expression of α-tubulin control detected with mouse 
monoclonal anti-α-tubulin antibodies (Sigma). The black arrows indicate the size of 
corresponding peptides. In ints5 morpholino injected embryos, truncated forms of 
Smad5, Smad5∆E4 (43kD, lack of 86 amino acids encoded by exon4 of smad5) and 
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Similarly, un-spliced smad1 transcripts are detected at several exon/intron boundaries in 
ints5 morpholino-injected embryos at 30% epiboly stage (Figure 4.4).  
However, we did not observe aberrant splicing of any exon/intron boundary of smad2, 
smad3a and smad3b transcripts or other examined transcripts, such as cyclops and squint 
(Figures 4.5, 4.6). Taking squint splicing as an example, aberrantly spliced squint 
transcripts were only detected in squint morphant but not in control and ints5 morphant 
(Figure 4.6)(Gore et al., 2005). These results show that Ints5 is specifically required for 
the correct splicing of smad1 and smad5 RNA. 
In fact, the splicing of many genes (including chordin, vent, vox, ved, gata2, eve1, 
smurf1, bmp2b, bmp7, ski, sqt, cyc and others) expressed in early gastrulation was 
checked in ints5 morphant and we find that among all the transcripts we examined, only 
smad1 and smad5 RNA splicing are affected. However, this does not exclude the 
possibility that Ints5 may regulate the splicing of other RNAs directly or indirectly, and 
smad1 and smad5 may not be the only targets for Ints5. 
U1 and U2 snRNAs are key components of the spliceosome and function in processing of 
most pre-mRNAs. It is postulated that knock-down of Ints5 disrupts the production of 
mature U1 and U2 snRNAs, which in turn affects spliceosome function and leads to 
aberrant smad1/5 splicing. To understand the mechanism underlying the smad1/5 splicing 
defects, we examined the transcription and processing of U1 and U2 snRNAs with 
different primer pairs (Figure 4.7A) in ints5 morphants. RT-PCR analysis shows more 
accumulation of un-processed primary U1 and U2 snRNAs in ints5 morpholino injected 
embryos (Figure 4.7B). Semi-quantitative RT-PCR was performed to determine the 
change in expression levels of the different U1 and U2 transcripts. The amount of 
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unprocessed primary U1 and U2 snRNA in ints5 morphants increased up to 2.4 fold and 
2.7 fold respectively (Figure, 4.7C, D). In contrast, levels of mature U1 and U2 snRNAs 
levels are relatively stable (Figure 4.7E, F). This can be explained by the long half life of 
U1 and U2 snRNA (Fury and Zieve, 1996). 
Therefore, it is likely that Ints5 functions through U1/U2 snRNA processing to regulate 
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Figure 4.4 Knockdown of Ints5 perturbs splicing of smad1 RNA.  
(A) Schematic representation of smad1 genomic loci.  Numbered black arrows indicate 
the position of primers used in RT-PCRs to detect splicing. The sizes of the predicted 
products are indicated on the right. (B) Un-spliced smad1 (386 bp product with primer 
pair 2+3) and correctly spliced smad1 (491 bp with primer pair 1+3) transcripts in 30% 
epiboly ints5 morpholino injected embryos. Splicing of β-actin is shown as control. 
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Figure 4.5 Knockdown of Ints5 does not perturb splicing of smad2 and smad3 RNA. 
(A) Schematic representation of the smad2, smad3a and smad3b genomic loci.  
Numbered black arrows indicate the position of primers used in RT-PCRs to detect 
splicing. The sizes of the predicted products using various primer pairs (shown in red) are 
indicated on the right. (B) Amplification of smad2, smad3a and smad3b with indicated 
primer pairs shows correctly spliced products in ints5 morphants. Amplification with the 
primers spanning other regions of these genes did not show aberrant splicing as well (data 
not.shown).  
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Figure 4.6. Knockdown of Ints5 dose not affect splicing of cyclops and squint RNA. 
 (A) Schematic representation of the cyclops and squint genomic loci. Arrows indicate the 
position of primer pairs used in RT-PCRs to detect splicing. The orange bar indicates the 
position of the squint splice junction morpholino at the exon2-intron2 boundary (Gore et 
al., 2005). Expected sizes of the amplified products are shown on the right. (B) At 30% 
epiboly, a 402 bp cyc product is detected from all cDNA templates, whereas a 993 bp 
fragment is amplified from genomic DNA. (C) Embryos injected with ints5 morpholinos 
or control morpholinos show the expected 615 bp squint product.  In contrast, embryos 
injected with squint splice-junction morpholinos show either un-spliced (696 bp) or 
aberrantly spliced squint transcripts (469 bp).  
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Figure 4.7 Knockdown of ints5 leads to accumulation of immature primary U1, U2 
snRNAs.  
(A) Diagrams of U1 and U2 snRNA genes. Location of the proximal promoter elements 
(PSE), snRNA coding region, the 3’ end formation signals (3’ Box) and terminators are 
indicated with rectangular boxes. The mature and immature primary forms of U snRNA 
transcripts are represented under each diagram. The numbered arrows indicate the 
position of primers used to detect the expression of various transcripts of U snRNA 
genes. (B) The presence of mature and primary U1 and U2 snRNAs was detected by RT-
PCRs with labeled primers (mature U1, 1+2; primary U1, 3+4; mature U2, 5+6; primary 
U2, 7+8) at 8 hpf. The expression of 18s rRNA is shown as control. (C-F) Histograms to 
show expression level of primary U1(C), Primary U2 (D), mature U1 (E) and mature U2 
(F) transcripts in injected embryos.  Expression levels were measured at 8 hpf by semi-
quantitative RT-PCR, normalized with respect to the level of 18s rRNA internal control, 
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4.2 INTS5 MODULATES HEMATOPOIESIS THROUGH SMAD/BMP 
SIGNALING 
If the hematopoiesis defects induced by knock-down of Ints5 are caused by mis-splicing 
of smad1 and smad5, providing correctly spliced smad1/5 should rescue the ints5 
morpholino induced defects in these embryos.  
To determine the epistatic relationship between Ints5 and Smad1/Smad5, we injected 10 
pg of capped synthetic smad1 or smad5 RNA together with ints5 morpholinos into one-
cell stage embryos and either fixed them at 6-somite stage (12 hpf) for WISH or raised 
them for blood extraction at 2 dpf.  
We found that co-injected smad1 or smad5 RNA can restore scl expression in ints5 
morphants, similar to ints5 RNA co-injections (Figure 4.8C, D, I-M, Table 4.1, P<<0.01, 
z test). Embryos injected with 10 pg of smad1 or smad5 RNA alone show normal scl 
expression (Figure 4.8E-H, M), similar to control morpholino-injected embryos (Figure 
4.8A, B, M).  
To rule out the possibility that the delayed development accounts for the reduced scl 
expression, we did double color WISH with scl and myoD in stage-matched embryos at 
6-somite stage. The anterior scl expression domain is missing in ints5 morphants (Figure 
4.9 B). The reduced anterior scl expression in ints5 morphants is rescued by co-injecting 
smad1 and smad5 RNA (Figure 4.9E, F)(Weinberg et al., 1996). The anterior limit of 
major scl expression domain aligns well with the most anterior myoD positive cells, 
similar to control and smad1/smad5 RNA injected embryos (Figure 4.9A, C, D). 
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Figure 4.8 The hematopoiesis defects induced by Ints5 knock-down are rescued by 
smad1 and smad5 RNA. 
(A-L) Whole mount in situ hybridization to detect scl expression in 12 hpf embryos 
injected with control morpholinos (A, B), ints5 morpholinos (C, D), smad1 RNA (E, F), 
smad5 RNA (G, H), ints5 morpholinos and smad1 RNA (I, J), or ints5 morpholinos with 
smad5 RNA (K, L). The black arrowheads indicate the anterior limit of scl expression in 
ICM. The open arrowheads indicate scl expression in RBI.  (A, C, E, G, I, K) show dorsal 
views of embryos with anterior to the top; (B, D, F, H, J, L) show lateral views of 
embryos with dorsal side to the right. (M) Histogram showing percentage of injected 
embryos with wild type like (blue) or reduced (magenta) scl expression.  Scale bar in (A, 
M), 50 µm. 
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Figure 4.9 The hematopoiesis defects induced by ints5 knock-down are rescued by 
smad1 and smad5 RNA.  
 (A-F) Whole mount in situ hybridization to detect scl (purple) and myoD (red) 
expression in 6-somite embryos injected with control morpholinos (A), ints5 morpholinos 
(B), smad1 RNA (C), smad5 RNA (D), ints5 morpholinos with smad1 RNA (E), or ints5 
morpholinos with smad5 RNA (F). (A-F) show flat-mounted embryos with anterior to the 
left. Scale bar in (A), 100 µm.  
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Table 4.1 Reduced scl expression in ints5 morphant embryos can be rescued by co-
injection of int5, smad1 and smad5 RNA. 














Con MO 5 ng 360 94.7 5.3 
Ints5 RNA 50 pg 253 96.8 3.2 
Smad1 RNA 10 pg 220 98.6 1.4 
Smad5 RNA 10 pg 221 99.1 0.9 
Ints5 acceptor + donor 
MO 
2.5+2.5 ng 295 33.2 66.8 
ints5 acceptor + donor 
MO + int5 RNA 
2.5+2.5 ng+50 pg 182 59.9 40.1 
ints5 acceptor + donor 
MO + smad1 RNA 
2.5+2.5 ng+10 pg 246 58.5 41.5 
ints5 acceptor + donor 
MO + smad5 RNA 
2.5+2.5 ng+10 pg 247 55.9 44.1 
 
To confirm the above results, semi-quantitative real-time PCR was performed to detect 
the expression level of scl and gata1 genes (relative to β-actin). The experiment also 
shows the reduced expression levels of these genes in ints5 morphant can be restored to 
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normal levels by co-injection of smad1 and smad5 RNA (Figure 4.10A, B). 
Ints5 knock-down inhibits blood formation and erythrocyte differentiation. We have 
already shown that blood formation can be rescued by wild type smad1, smad5 
transcripts. We further investigated red blood cell differentiation defect, and found that 
~50% of RBCs arrested in ints5 morphants (Figure 4.11B, G, n=378). Over-expressing 
smad1 or smad5 at 10 pg dose had no effect on RBC differentiation (Figure 4.11C, D, G, 
n=255 and n=493). However, normal differentiation of RBCs in ints5 morphants was 
restored by co-injection of smad1 and smad5 RNA (Figure 4.11 E-G, n=257 and n=380, 
respectively) at 2 dpf. Thus, co-injecting of smad1, smad5 rescued the RBC 
differentiation defects seen in the ints5 morphants. 
Taken together, these results show that Ints5 functions in hematopoiesis by regulating 
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Figure 4.10 The reduced hematopoiesis gene expression induced by ints5 knock-
down are rescued by smad1 and smad5 RNA.  
Histograms to show expression level of gata1 (A) and scl (B) in injected embryos.  
Expression levels were measured at 12 hpf by semi-quantitative RT-PCR, normalized 
with respect to the level of β-actin internal control, and shown as fold-change relative to 
control embryos.   
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Figure 4.11 The red blood cell differentiation defects induced by Ints5 knock-down 
are rescued by smad1 and smad5 RNA.  
(A-F) May-Grunwald Giemsa staining to show RBCs differentiation in embryos injected 
with control morpholinos (A), ints5 morpholinos (B), smad1 RNA (C), smad5 RNA (D), 
ints5 morpholinos and smad1 RNA (E), or ints5 morpholinos with smad5 RNA (F) at 2 
dpf. (G) Histograms showing percentage of RBCs with normal (blue) or arrested 
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As Ints5 is a subunit of the Integrator complex (Baillat et al., 2005), to find out whether 
Ints5 function independently or as a part of the Integrator complex in hematopoiesis, we 
examined the activity of other Integrator subunits Ints9 and Ints11, which display 
similarities to the subunits of the cleavage and polyadenylation specificity factor (CPSF) 
complex (Baillat et al., 2005). 
We injected ints11 ATG morpholinos and splice morpholinos targeting the boundary of 
intron4-exon5 in the ints11 gene into one-cell stage embryos and fixed them for WISH at 
different stages (Figures 5.1, 5.2). Both ints11 morpholinos cause reduced expression of 
the hematopoietic markers, scl and gata1 (Figures 5.1C, D, G, 5.2B, D) in more than 50% 
embryos. In addition, embryos injected with ints9 splice morpholinos targeting the 
boundary of intron2-exon3 show similar hematopoiesis defects, albeit to a less extent 
(Figures 5.1E-G, 5.2C, D). Furthermore, morpholinos targeting the splice junction of 
ints11 not only cause aberrant splicing of ints11 transcripts (Figure 5.3) but also disrupt 
U1/U2 snRNAs processing (Figure 4.7B) and smad5 splicing (Figure 5.4) in the same 
manner as ints5 splice morpholinos. Therefore, multiple subunits of the Integrator 
complex, including Ints5, may be required for appropriate hematopoietic gene 
expression. These results suggest that the Integrator proteins may function as a complex 
to regulate primitive hematopoiesis in zebrafish by modulating smad1/5 splicing, via the 
spliceosome. 
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Figure 5.1 Multiple subunits of the Integrator complex regulate primitive 
hematopoiesis.  
Whole mount in situ hybridization to detect scl (A-F) in embryos injected with control 
morpholinos (A, B), ints11 splice junction morpholinos (C, D) and ints9 splice junction 
morpholinos (E, F). The black arrowhead indicates the anterior limit of scl expression in 
the ICM. The ints9 and ints11 morphants show substantially reduced scl and gata1 
expression in comparison to control morphants. (G) Histograms showing percentage of 
injected embryos with wild type like (blue) or reduced (magenta) scl expression. Scale 
bars in (A), 50 µm.  
Chapter V          The Integrator Complex Regulates Primitive Hematopoiesis 158 
 
Chapter V          The Integrator Complex Regulates Primitive Hematopoiesis 159 
Figure 5.2 Multiple subunits of the Integrator complex regulate primitive 
hematopoiesis. 
 Whole mount in situ hybridization to detect gata1 (A-C) in embryos injected with 
control morpholinos (A) ints11 splice junction morpholinos (B) and ints9 splice junction 
morpholinos (C). The black arrowhead indicates the anterior limit of scl expression in the 
ICM. The ints11 morphants show substantially reduced scl and gata1 expression in 
comparison to control morphants. (D) Histograms showing percentage of injected 
embryos with wild type like (blue) or reduced (magenta) gata1expression. Scale bars in 
(A), 250 µm.  
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Figure 5.3 The effect of ints11 splice morpholino. 
(A) Schematic representation of the ints11 genomic locus. Numbered black arrows 
indicate the position of primers used in RT-PCRs to detect splicing. The orange bar 
shows the target site of the ints11 splice-site morpholino. (B) RT-PCR analysis shows 
that the ints11 splice junction morpholino disrupts correct splicing of ints11 RNA. (C) 
Protein sequence of Ints11. The four amino acids in red form the catalytic center of 
Ints11, which resides at the beginning of exon5. (D) Schematic representation of normal 
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Figure 5.4 Knock-down of ints11 perturbs smad5 splicing.  
(A) Schematic representation of the smad5 genomic locus. Numbered black arrows 
indicate the position of primers used in RT-PCRs to detect splicing. (B) RT-PCR analysis 
shows that splicing of smad5 is impaired in ints11 morphants at 30% epiboly. (C) 
Schematic representations of normal and aberrantly spliced smad5 transcripts.
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6.1 INTS5 IS REQUIRED FOR MULTIPLE FUNCTIONS DURING 
EARLY DEVELOPMENT 
A gradient of BMP activity specifics dorsal-ventral fates in early zebrafish embryos 
(Kishimoto et al., 1997; Schier and Talbot, 2005). It may seem surprising that although 
Ints5 knockdown affects smad1/5 splicing, we do not observe early dorso-ventral 
patterning and germ layer specification defects (Figures 3.6, 3.7), as observed for smad5 
and other BMP pathway mutants (Dick et al., 2000; Hild et al., 1999; Kishimoto et al., 
1997; Kodjabachian et al., 1999; Mullins et al., 1996; Schmid et al., 2000; Schulte-
Merker et al., 1997). This can be explained by the maternal deposition of Integrator 
complex factors such as Ints5 (Figure 3.2). The maternal Int proteins may allow normal 
functioning of the Integrator complex in early embryos, such that the early patterning 
events that are mediated by BMP signaling are not affected by knockdown of Ints5. The 
maternal function of Ints5 is difficult to study and remains elusive.  
However, hematopoietic marker scl is only strongly expressed after gastrulation, when 
production of Ints5 protein has been disrupted by anti-sense morpholino oligos (Figure 
3.4) (Gering et al., 1998). Therefore, the effects of ints5 morpholino manifested on 
hematopoiesis. 
We also observe convergence-extension (CE) cell movement defects in ints5 morphants 
during gastrulation (Figure 3.7E-H). Later during somitogenesis, the bigger distance 
between the two strips of scl expressing cells in the intermediate cell mass (ICM) is also 
due to the early cell movement defects (Figures 3.9C, 3.11D). We found that, by 
monitoring the expression of ntl/dlx3/hgg1, co-injected smad1 or smad5 RNA not only 
restored blood formation in ints5 morphants, but also rescued their CE defects (Figure 
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6.1C, D, I-L, M). Embryos injected with 10 pg of smad1 or smad5 RNA alone show 
normal CE movement (Figure 6.1E-H, M), similar to control morpholino-injected 
embryos (Figure 6.1A, B, M).  
Thus, Ints5 is required for proper CE cell movement at mid-gastrulation stages (Figure 
3.7F), and it is possible that the Integrator subunits regulate this process through smad1/5 
splicing as well. However, further investigation is required to confirm this. 
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Figure 6.1 Convergent-extension defects in ints5 morphants are rescued by smad1 
and smad5 RNA.   
(A-L) Whole mount in situ hybridization to detect ntl, dlx3 and hgg1 expression in 
tailbud (TB, 10 hpf) embryos injected with control morpholinos (A, B), ints5 
morpholinos (C, D), smad1 RNA (E, F), smad5 RNA (G, H), ints5 morpholinos and 
smad1 RNA (I, J), or ints5 morpholinos with smad5 RNA (K, L). Black arrowheads 
indicate the anterior limit of ntl expression in the midline, and red arrows indictae hgg1 
staining in the anterior prechordal plate mesendoderm cells. White arrowheads and dotted 
lines indicate the distance between the lateral limits of dlx3 expression in the 
neuroectoderm. (A, C, E, G, I, K) show lateral views of embryos with dorsal to the right; 
(B, D, F, H, J, L) show animal pole views of embryos. (M) Histogram showing 
percentage of injected embryos with wild type (WT, blue) or impaired (magenta) cell 
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6.2 THE INTEGRATOR SPECIFICALLY REGULATES BMP/SMAD 
SIGNALING.   
The Integrator complex is thought to function in RNA processing, which is important for 
every cell. However, my findings show that only smad1 and smad5 splicing are affected 
in ints5 morphants whereas expression of other smads (for e.g., smad 2, smad3a, smad3b) 
is not disrupted, suggesting that the Int complex does not generally affect all smad 
splicing. Furthermore, our analysis of several other genes (eg, sqt, cyc and others) shows 
that disruption of Integrator complex function does not generally affect genes expressed 
during gastrulation. In addition, depletion of Ints5 in Drosophila germarium specifically 
affects Dpp signaling activities, which in turn leads to no differentiated mature oocytes 
(Cai et al., unpublished data). This raises the possibility that the Integrator complex has a 
specific effect on BMP/SMAD signaling or functions specifically in the cells that respond 
to BMP signaling, so as to regulate hematopoiesis.  
One interesting question is to understand how Integrator subunits specifically regulate 
BMP/SMAD signaling, although they are proteins with presumed house keeping 
functions. In fact, it is gradually known that mutations in some transcription or translation 
machinery components can lead to very specific defects in distinct cell-types (Pellizzoni, 
2007; van der Knaap et al., 2006). For example, the vanishing white matter disease 
(VWM) is characterized by early childhood onset of chronic neurological deterioration. 
The basic defect of this striking disease resides in any of the five genes encoding the 
subunits of eukaryotic translation initiation factor eIF2B, which is essential in all cells for 
protein synthesis. Although the defect is in housekeeping genes, oligodendrocytes and 
astrocytes are predominantly affected, whereas other cell types are surprisingly spared. 
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The selective vulnerability of glia for defects in eIF2B mutant is poorly understood (van 
der Knaap et al., 2006).  
In addition, the survival motor neuron (SMN) protein is part of a macromolecular 
complex that functions in the biogenesis of small nuclear ribonucleoproteins (snRNPs), 
which are essential for pre-mRNA splicing. Reduced level of SMN expression causes the 
inherited motor neuron disease spinal muscular atrophy (SMA) (Pellizzoni, 2007). Work 
in recent years show that the SMN complex acts as a macromolecular chaperone of 
snRNPs to increase the efficiency and fidelity of RNA–protein interactions in vivo, and to 
provide an opportunity for these interactions to be regulated (Pellizzoni, 2007). It is 
indicated that the RNA metabolism deficiencies underlying SMA affect the homeostasis 
of specific mRNAs encoding proteins essential for motor neuron development and 
function. 
Similarly, Diamond-Blackfan anemia (DBA) has long been a puzzle for hematologists. 
This syndrome is characterized by defective erythropoiesis, low stature and 
malformations (Shimamura, 2008). It is caused by mutations in human ribosomal 
proteins, mainly ribosomal protein S19 (RPS19). Human cells with RPS mutation are not 
able to process ribosomal RNA (rRNA) (Dianzani and Loreni, 2008). Recently, Uechi et 
al. developed an RPS19-deficient zebrafish by knocking down rps19 using an anti-sense 
morpholino oligo. The RPS19-deficient animals showed a dramatic decrease in blood 
cells as well at early developmental stages. These phenotypes can be rescued by injection 
of zebrafish rps19 mRNA, but not by injection of rps19 mRNAs with mutations that have 
been identified in DBA patients (Uechi et al., 2008). These results indicate that rps19 is 
essential for hematopoietic differentiation during early embryogenesis. It is also reported 
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that increased abnormally spliced forms of FLVCR1 are observed in DBA immature 
erythroid cells, although FLVCR1 itself is not mutated (Rey et al., 2008). The FLVCR 
protein is a heme exporter and the receptor for the subgroup C leukemia retrovirus. A 
phenotype similar to DBA is shown by Flvcr1 null mice as well (Keel et al., 2008). These 
discoveries suggest a possible functional link between rRNA processing and 
erythropoiesis through FLVCR1 transcript splicing. However, the definite role of 
FLVCR1 in regulating erythropoiesis is not clear. Neither it is known how exactly a 
defect in RPS19 or other RPS genes can influence FLVCR1 splicing specifically. 
Recent work by Watanabe et al. has shown that SF3b4, a subunit of SF3b which is a 
common RNA splicing complex, specifically binds to BMPR-1A and inhibits BMP 
signaling during osteochondral cell differentiation (Watanabe et al., 2007).  There may be 
a potential connection between TGFβ/BMP signaling and the small RNA or RNA 
processing machinery. So it is possible that Ints5, which is involved in U1/U2 snRNA 
maturation, which in turn is important for the pre-mRNA splicing, may cooperate with 
other RNA splicing factors in specific cellular contexts (such as hematopoietic 
progenitors), to specifically modulate BMP signaling via smad1/smad5 RNA splicing.  
Alternatively, the post-transcriptional process of certain BMP signaling components 
(such as Smad1/5) is simply more sensitive than that of other genes during early zebrafish 
development.  
 
6.3 SMAD5 SPLICING IS IMPORTANT FOR HEMATOPOIESIS  
Although hematopoiesis has been extensively studied, the molecular program of 
hematopoietic stem cell induction and self-renewal remains unclear. Smads are 
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evolutionarily conserved transducers of the differentiation and growth arrest signals from 
the transforming growth factor β/BMP (TGF-β/BMP) family of ligands. Upon BMP 
receptor activation, the receptor regulated Smad1, 5, 8 are phosphorylated in the C-
terminal MH2 domain and recruit the common subunit Smad4 to the nucleus to mediate 
target gene expression (Heldin et al., 1997; Kretzschmar and Massague, 1998; Massague, 
1998). The TGF-β/BMP superfamily of multifunctional cytokines regulates proliferation, 
differentiation, and apoptosis in hematopoietic cells and a variety of other tissues and cell 
types (Eaves et al., 1991). Homozygous SMAD5 null mice undergo embryonic lethality 
with abnormal vasculature and blood cells (Chang et al., 1999; Yang et al., 1999). Recent 
studies demonstrate that SMAD1 and SMAD5, as well as the type I receptors ALK3 and 
ALK6, are expressed in CD34+CD38-lin- human hematopoietic stem cells, which are 
capable of giving rise to all the lineages in nonobese diabetic/severe combined immune 
deficient (NOD/SCID) mice (Bhatia et al., 1999). Despite the growing body of evidence, 
very little is known about the mechanisms underlying the differential regulation of 
hematopoiesis by TGF-β/BMP.  
Recent work has revealed that the post-transcriptional processing of BMP Smads is 
involved in maintenance of hematopoietic stem cell identity.  Jiang et al. identified a 
ubiquitously expressed novel isoform, SMAD5β, which encodes a 351 amino acid 
protein with a truncated MH2 domain and a unique C-terminal tail of 18 amino acids 
(Jiang et al., 2000). Yeast 2-hybrid interaction assays reveal that the SMAD5β isoform 
does not homodimerize or heterodimerize with SMAD5 or SMAD4, so it may be the 
functional equivalent of inactivating mutations. Smad5β is expressed in both normal 
hematopoiesis and leukemogenesis (Jiang et al., 2000). Interestingly, the expression level 
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of the smad5β isoform is higher in CD34+ hematopoietic stem cells than in terminally 
differentiated peripheral blood leukocytes, thereby implicating a function for the β form 
in stem cell homeostasis (Jiang et al., 2000).  It is also indicated that the alternative 
splicing of smad5 is differentially regulated during maturation of hematopoietic cells.  
Our work shows that the splicing of smad1/5 is impaired by knockdown of Ints5. 
Aberrant splicing of smad5 leads to production of dominant negative forms of Smad5, the 
over-expression of which phenocopies the hematopoiesis phenotypes we observe in ints5 
morphants. These include reduced expression of scl, and eventually, failure in erythrocyte 
differentiation. Thus, accurate splicing of smad5 is crucial for the normal progression of 
hematopoiesis and erythropoietic differentiation, and the failure to generate appropriate 
Smad5 products can lead to a reduction of hematopoietic progenitors. 
 
6.4 SPECULATION: DYSFUNCTION OF INTEGRATOR SUBUNITS 
IS INVOLVED IN DISEASE  
Eukaryotic pre-mRNA splicing allows for a large, diverse proteome to be coded by a 
relatively small genome. Usually alternative splicing events are well regulated, but when 
mutations disrupt the splicing machinery, disease can occur, as mutations can cause 
disease through aberrant transcript production. As the Integrator complex plays a vital 
role in transcription and processing of snRNA, which in turn regulate pre-mRNA 
processing, dysfunction of the Integrator subunits may lead to various defects. 
In our study, knockdown of Integrator subunits leads to defects in zebrafish 
erythropoiesis differentiation. It is possible that mutations of ints can cause syndromes 
Chapter VI                                            Discussion 174 
similar to DBA disease in human. Therefore, it is worth sequencing each Integrator 
subunit in the human patients with anemia or unidentified anemia cell lines. If ints are 
anemia related genes, the ints-deficient zebrafish will provide a valuable model for 
investigating the molecular mechanisms of anemia development in humans. 
Besides, deficiencies in mRNA splicing have also been shown to cause many other 
genetic disorders (Pellizzoni, 2007; Solis et al., 2008). In fact, recent work has shown that 
disruption of the murine Integrator subunit 1 (Ints1) causes growth arrest and eventual 
apoptosis at early blastocyst stages (Hata and Nakayama, 2007). Ints1-/- embryos have 
increased levels of unprocessed primary U2 snRNA transcripts but decreased levels of 
mature U2 snRNA transcripts compared to heterozygotes. Thus, Ints1 is suggested to 
play a non-redundant role, for instance, as a scaffold for the assembly of the Integrator 
complex, in the mouse embryo (Hata and Nakayama, 2007). In addition, Integrator 
subunit 3 is a probable target for the 1q21 amplification found in most hepatocellular 
carcinoma (HCC) tumors, and may be involved in the development and/or progression of 
this cancer (Inagaki et al., 2008). 
However, it is still unclear how these genes function, and how their malfunction leads to 
profound defects in specific biological processes. The study presented here reveals a 
potential link between snRNA processing and BMP signaling in hematopoiesis.  
Understanding the precise mechanisms by which the individual subunits function may 
provide insights into the roles played by the Integrator complex during development and 
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Hematopoiesis is the process that gives rise to all types of blood
cells. It is generally believed that hematopoietic development
branches at an early stage into myeloid and lymphoid cell fates. The
lymphoid branch differentiates to T, B and natural killer cells, and
the myeloid branch develops into all the other cell types, including
monocytes/macrophages, granulocytes, megakaryoctyes and
erythrocytes (red blood cells, RBCs) (Hsu et al., 2001; Larsson and
Karlsson, 2005). In the mouse, the hemangioblast progenitors
(common progenitors for both hematopoietic and endothelial
lineages) arise from a mesodermal population of cells positive for
brachyury (T) expression (Fehling et al., 2003). Similarly, in
zebrafish, hemangioblasts originate from the ventral margin of the
embryo (Vogeli et al., 2006). Primitive hematopoiesis occurs at two
anatomical sites: the rostral blood island (RBI) arising from the
cephalic mesoderm and the intermediate cell mass (ICM) located in
the trunk, ventral to the notochord. Cells within the ICM
predominantly differentiate into vascular cells and primitive
erythrocytes, which enter the blood circulation around 24 hours post
fertilization (hpf) (Al-Adhami and Kunz, 1977; Davidson and Zon,
2004).
Recent work has shown that the process of blood cell formation
is regulated by a variety of intrinsic transcription factors. These
include the Stem cell leukemia (Scl, Tal1 – ZFIN) basic helix-loop-
helix transcription factor, and a zinc-finger transcription factor,
Gata1. scl is expressed in the RBI and the ICM, where its expression
marks the formation of primitive hematopoietic stem cells (HSCs)
and vascular precursors. gata1 is expressed in the lateral plate
mesoderm that will migrate medially to form the ICM and is crucial
for myeloid differentiation (de Jong and Zon, 2005). Many
extracellular signaling molecules present in the environment are also
involved in hematopoietic regulation. These include the bone
morphogenetic proteins (BMPs). BMPs belong to the Transforming
growth factor β (TGF-β) family of secreted proteins, and signal via
the downstream transcription factors, Smad1, 5 and 8 (Smad9 –
ZFIN) (von Bubnoff and Cho, 2001). BMP signaling is important
not only for the patterning of ventral mesoderm from where the
primitive HSCs arise, but also for regulating the specification and
proliferation of blood progenitors (Larsson and Karlsson, 2005;
Winnier et al., 1995). Loss of either Smad1 or Smad5 leads to a
failure in the generation of definitive hematopoietic progenitors in
zebrafish (McReynolds et al., 2007).
Integrator is a multiprotein complex that associates with the C-
terminal repeats of RNA polymerase II and mediates U1 and U2
snRNA 3 end processing (Baillat et al., 2005). Here, we report that
the snRNA metabolism-related factor Ints5, a subunit of the
Integrator complex, functions in zebrafish hematopoiesis by
modulating the splicing of smad1 and smad5 RNA, thereby
establishing a potential link between the RNA processing machinery




Zebrafish were maintained under standard conditions at 28.5°C and embryos
were obtained by standard breeding methods. All experimental procedures
were carried out according to the guidelines of the Institutional Animal Care
Use Committee at Temasek Life Sciences Laboratory.
5 and 3 RACE
Total RNA was extracted from wild-type embryos and subjected to 5 and
3RACE using the FirstChoice RLM-RACE Kit (Ambion) according to the
manufacturer’s instructions. The following primers were used: Ints5 5
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RACE, 5-TCACCCTATGCAGGCCTTGTAGA-3 and 5-GGGAGT -
AGCACTCCATTAGTGA-3; Ints5 3 RACE, 5-GCTACTTCCTC -
CAGTCTTGAGT-3 and 5-CGCTGTGCTATTGCTCTGTCAT-3. The
RACE products were cloned into the plasmid pCS2+ and sequenced.
In situ hybridization analyses
Whole-mount in situ hybridization was performed as described (Tian et al.,
2003). The following plasmids were linearized and antisense probes were
synthesized by in vitro transcription: pBSints5 (BamHI, T3 RNA
Polymerase), pGEMT-Easyscl (NcoI, SP6 RNA Polymerase), pBSgata1
(XbaI, T7 RNA Polymerase), pBSflk1 (SmaI, T7), pKSpax2a (BamHI, T7)
(Detrich et al., 1995; Gering et al., 1998; Liao et al., 1997; Majumdar et al.,
2000), pBShgg1 (XbaI, T7) (Thisse et al., 1994), pBSgsc (EcoRI, T7) (Thisse
et al., 1994), pBSntl (XhoI, T7) (Schulte-Merker et al., 1994), pBSspt (EcoRI,
T7) (Griffin et al., 1998), pBSsox17 (EcoRI, T7) (Alexander and Stainier,
1999), pBSmyoD (BamHI, T7) (Weinberg et al., 1996) and pBSdlx3 (SalI,
T7) (Akimenko et al., 1994). For digoxigenin- and fluorescein-labeled
probes, BM Purple (Roche) and Fast Red (Sigma) substrates were used.
Injection of morpholinos and RNA
All morpholinos were obtained from GeneTools. The ints5 donor and
acceptor morpholinos were designed to target the splice site. Co-injection of
the two ints5 morpholinos (donor and acceptor MO) at an optimal dose of
2.5 ng each was found to have better efficiency, and all injections, unless
otherwise specified, were performed using this combination. The ints11
ATG morpholino was injected at a dose of 25 ng/embryo. The ints9 SMO
targeting the intron2-exon3 boundary of ints9 was used at a dose of 12.5
ng/embryo. The ints11 SMO targeting the intron4-exon5 boundary was
injected at a dose of 2.5 ng/embryo. The morpholino sequences are: Ints5
donor MO, 5-CTTGTATTGCTCACCTGTAA-3; Ints5 acceptor MO,
5-AGCTCTTGAGGACTGATGGA-3; Ints9 SMO, 5-GATAATCGTG -
GACTGTAAATCCAAC-3; Ints11 ATG MO, 5-AAGGCGTAACTTT -
GA TATCAGGCAT-3; Ints11 SMO, 5-AGATGGAAATGACTGAG AG -
GAAGAG-3. cDNAs encoding Ints5, Ints9, Ints11, Smad1 and Smad5
were cloned in pCS2+. For injection, constructs were digested with NotI and
the capped mRNA was synthesized with the mMESSAGE mMACHINE
SP6 Kit (Ambion) according to the manufacturer’s instructions. For rescue
experiments, 50 pg of ints5 RNA or 10 pg of smad1 and smad5 RNA was
co-injected with ints5 morpholinos.
RT-PCR
Total RNA from injected embryos (1 μg) was used to generate cDNA with
Superscript II Reverse Transcriptase (Invitrogen) and p(dT)15 or random
p(dN)6 primers (Roche). The cDNA was then used in a PCR reaction. Primer
details are available upon request.
May-Grunwald Giemsa staining
Fish embryos were anesthetized in PBS (pH 7.4, calcium- and magnesium-
free) with 0.02% tricane (Sigma) and 1% BSA. After tail clipping, red blood
cells were collected and cytospun onto slides by centrifugation at 400 rpm
for 3 minutes using a Cytospin 4 Cytocentrifuge (Thermo Scientific). The
slides were air-dried and subjected to May-Grunwald Giemsa staining (Qian
et al., 2007).
Smad cDNA constructs
Smad5Δexon4 and Smad5Δexon4,5 were generated by PCR amplification
from cDNA templates (Dick et al., 1999) using the following primers:
Smad5Δexon4 F, 5-CACTACAAACGAGTTGAAAGTCCAGCTGAT-
ACTCCTCCTCCTGCCTACAT-3; Smad5Δexon4 R, 5-ATGTA -
GGCAGGAGGA GGAGT ATCAGCTGGACTTTCAA CTCGTT TGTA G -
TG-3; Smad5Δexon4,5 F, 5-CACTACAAACGAGTTGA AAGT -
CCAGATGTGCAGCCAGTGGA GTATCAGGA-3; Smad5Δexon4,5 R,
5-TCCTGATACTCCACTG GCTGCACATCTGGACTTTCAA CTC GT -
TTGTAGTG-3.Constructs were linearized with NotI and capped mRNA
was synthesized with the mMESSAGE mMACHINE SP6 Kit (Ambion).
Quantitative real-time PCR
First-strand cDNA was synthesized using Superscript II Reverse
Transcriptase (Invitrogen). Semi-quantitative real-time PCR was performed
with the Power SYBR Green PCR Mix (Applied Biosystems) on the
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Fig. 1. Ints5 functions during hematopoiesis. (A) Schematic
representation of the ints5 genomic locus; orange bars indicate
target sites of the donor and acceptor morpholinos (MOs);
numbered black arrows show the position of the primers used in RT-
PCRs to examine splicing of ints5 RNA. (B) RT-PCR to detect splicing
of ints5 and control β-actin (encoded by bactin1). RNA from sphere
stage (4 hours post fertilization, hpf) embryos injected with control
or ints5 donor and acceptor morpholinos at the 1-cell stage. Primers
used (left) and transcript sizes (right) are indicated. G, genomic DNA.
(C) Schematic representation of correctly spliced (upper) and
aberrantly spliced (lower) ints5 transcripts. The size of bands
amplified by primer pair 1 and 4 is indicated on the right. Red open
arrowhead indicates the position of a cryptic splice site in exon 1.
(D-F) DIC images of live embryos at 24 hpf injected with control
morpholinos (D), ints5 acceptor and donor (a+d) morpholinos (E) or
co-injected with ints5 morpholinos and ints5 RNA (F). (G-Q) Whole-
mount in situ hybridization to detect expression of scl (G-N) at 12
hpf and gata1 (O-Q) at 26 hpf shows reduced expression of both
genes in ints5 morphants (I,J,P), in comparison to control
morpholino- or lacZ RNA-injected embryos (G,H,O). Black
arrowheads indicate the anterior limit of scl expression in the
intermediate cell mass (ICM); open arrowheads indicate scl
expression in the rostral blood island (RBI); black arrows indicate
anterior gata1 expression, which represents the circulating blood
cells. Co-injection of ints5 RNA can restore scl and gata1 expression
in ints5 morphants (M,N,Q), whereas embryos injected with ints5
RNA alone show normal scl expression at 12 hpf (K,L). D-F,O-Q show
lateral views of embryos with anterior to the left; G,I,K,M show
dorsal views of embryos with anterior at the top; H,J,L,N show lateral
views of embryos with dorsal to the right. Scale bars: 250 μm in D,O;










7900HT Fast Real-Time PCR System (Applied Biosystems). Each PCR
reaction was performed in triplicate, and each experiment was repeated
three times. The PCR cycle conditions were 95°C, 10 minutes and then
94°C, 15 seconds; 60°C, 1 minute, for 45 cycles. The CT values were
analyzed using the 2-ΔΔT method. Primer details are available upon
request.
Western blots
Western blots were performed on extracts of embryos after removing the
yolk. Proteins of each sample were harvested from 20 injected embryos at 8
hpf, separated using SDS-PAGE and transferred to a nitrocellulose
membrane (Amersham Biosciences, RPN203E). Ints5 proteins were
detected using rabbit anti-Ints5 antibody (1:1000, Bethyl Laboratories).
Smad5 proteins were detected using rabbit anti-Smad5 polyclonal antibody
(1:500, Abcam). The expression of theα-Tubulin control was detected using
anti-α-Tubulin antibody (1:1000, Sigma). Anti-mouse immunoglobulins
(1:5000, DAKO) or anti-rabbit immunoglobulins (1:5000, DAKO) were
used as secondary antibodies and were detected with SuperSignal West
Femto Maximum Sensitivity Substrate (Pierce) or with SuperSignal West
Pico Chemiluminescent Substrate (Pierce).
RESULTS
Ints5 functions during primitive hematopoiesis.
To investigate the function of Ints5 during early zebrafish
development, two antisense morpholinos were designed to target the
intronic donor and acceptor sites of the ints5 gene (Fig. 1A). Reverse
transcription-PCR (RT-PCR) analysis shows the accumulation of
nonspliced ints5 transcripts in embryos injected with ints5 splice-
junction morpholinos (Fig. 1B). Sequence analysis of RT-PCR
products from the transcripts shows that the correct exon-intron
boundary is not chosen and, instead, a cryptic site in exon 1 of ints5
is used in the morphant embryos. This leads to the production of
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Fig. 2. Ints5 knockdown affects hematopoietic progenitors but
not pronephric cells. (A-F) In situ hybridization to detect expression of
scl (purple) in hematopoietic cells, pax2a (red) in the pronephric cells
and flk1 (purple) in endothelial cells. (A,B) scl and pax2a expression in
control (A) and ints5 morphants (B) at 16 hpf. Black arrowheads
indicate the anterior scl expression in the ICM, and its reduction in ints5
morphants; pax2a expression is unaffected. (C-F) Expression of flk1 in
control (C,E) and ints5 morphants (D,F) at 12 hpf (C,D) and 15 hpf (E,F).
Red arrowheads indicate flk1 expression, which is much reduced in
ints5 morphants at an early stage (C,D) but recovers later in
development (E,F). (G-J) Expression of flk1 in injected embryos at 24
hpf. Insets show enlarged views of the boxed areas. Inter-segmental
flk1 expression is not detected in ints5 morphants (H), in comparison to
control embryos (G) and ints5 RNA-injected embryos (I). Expression of
flk1 in inter-segmental vessels is rescued by co-injection of ints5 RNA
(J). A-D show dorsal views of flat-mounted embryos; E,F show dorsal
views with anterior to the left; G-J show lateral views of the trunk
with anterior to the left. Scale bars: 100μm in A,C,E,G; 50μm in inset
in G.
Fig. 3. Ints5 is required for erythrocyte differentiation. (A-C) May-
Grunwald Giemsa staining shows normal red blood cells (RBCs) at
various stages of differentiation at the indicated embryonic stages.
(D-F) RBCs in embryos injected with control morpholinos (D), ints5
morpholinos (E), or co-injected with ints5 RNA and morpholinos (F) at 2
dpf. Arrows indicate the RBCs arrested at the basophilic erythroblast
stage (E). (G-I) RBCs in embryos injected with control morpholinos (G),
ints5 morpholinos (H), or co-injected with ints5 RNA and morpholinos
(I) at 7 dpf. (J,K) Histograms showing the percentage of RBCs with
normal (blue) or arrested (magenta) differentiation in injected embryos











incorrectly spliced ints5 transcripts lacking 170 bp of the coding
sequence (Fig. 1C). Western blot analysis using antibodies to detect
Ints5 protein in embryo extracts shows that the ints5 morpholinos
disrupt the synthesis of Ints5 proteins (see Fig. S1 in the
supplementary material).
By 24 hpf, embryos injected with ints5 splice-junction
morpholinos showed severe defects, with a shortened anterior-
posterior axis and no circulating blood cells (Fig. 1E,P), in
comparison to control morpholino- or RNA-injected embryos (Fig.
1D,O), indicating defects in convergent-extension cell movement
and hematopoiesis. These phenotypes were rescued by co-injecting
ints5 RNA with the ints5 splice-junction morpholinos (Fig. 1F,Q).
To determine if specification of the germ layers is affected in the
ints5 morphant embryos, we examined the expression of various
germ-layer and cell-type specific marker genes during gastrulation
(see Figs S2 and S7 in the supplementary material). Analysis of the
expression of ntl (ntla – ZFIN) and spt (tbx16 – ZFIN) in the
mesoderm, gsc in the dorsal organizer, dlx3 (dlx3b – ZFIN) in the
neural plate, sox17 in the endoderm and myoD (myod1 – ZFIN) in
the myotome showed that knockdown of ints5 does not affect germ-
layer specification. Furthermore, the patterning of dorsoventral and
anterior-posterior axes was largely normal, and the shortened axis
in ints5 morphant embryos is therefore likely to be a result of
impaired convergent-extension cell movements.
Since blood circulation is impaired in ints5 morphants, we
examined the expression of the hematopoietic genes stem cell
leukemia (scl) and gata1 by whole-mount in situ hybridization. The
expression of scl transcripts was severely reduced in ints5 morphants
(Fig. 1I,J; Fig. 2B; see Fig. S7B in the supplementary material) in
comparison to control embryos (Fig. 1G,H; Fig. 2A; see Fig. S7A in
the supplementary material). By contrast, the adjacent pax2a-
expressing pronephric cells were not affected in ints5 morphants
(Fig. 2A,B) (Majumdar et al., 2000). The expression of gata1, which
is crucial for the specification of erythrocytes, was also reduced in
ints5 morphants (Fig. 1P) (Orkin and Zon, 1997). This reduction is
rescued by the co-injection of ints5 RNA (Fig. 1M,N,Q), whereas
overexpression of ints5 RNA by itself does not affect scl or gata1
expression (Fig. 1K,L; data not shown). Semi-quantitative RT-PCR
to determine the levels of scl and gata1 RNA also show reduced
expression of these genes in ints5 morphants (see Fig. S3A,B in the
supplementary material), which is rescued by co-injection of ints5
RNA. Together, these experiments show that Ints5 function is
required during primitive hematopoiesis.
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Fig. 4. Knockdown of Ints5 perturbs splicing of smad1 and
smad5 RNA. (A) Schematic representation of the smad5, smad1,
smad2, smad3a and smad3b genomic loci. Numbered black arrows
indicate the position of primers used in RT-PCRs to detect splicing. The
sizes of the predicted products using various primer pairs are indicated
on the right. (B) At both sphere and 30% epiboly stages, aberrantly
spliced smad5 transcripts accumulate in ints5 donor morpholino (DM)-
and acceptor mopholino (AM)-injected embryos. β-actin control
transcripts are correctly spliced to yield a 500 bp product from cDNA in
comparison to a 700 bp genomic DNA product, G. (C) Schematic
representation to show the wild-type 710 bp smad5 transcript, and
aberrant smad5 transcripts that lack exon 4 (466 bp product), or lack
both exon 4 and exon 5 (350 bp product). (D) Unspliced smad1 (386 bp
product with primer pair 4 and 5) and correctly spliced smad1 (491 bp
with primer pair 3 and 4) transcripts in 30% epiboly ints5 morpholino-
injected embryos. (E) Amplification of smad2, smad3a and smad3b
with the primer pairs indicated in A shows correctly spliced products in
ints5 morphants. Amplification with primers spanning other regions of
these genes also did not show aberrant splicing (data not shown).
(F,G) Overexpression of truncated smad5 transcripts causes
hematopoiesis defects, similar to ints5 morphants. (F) Whole-mount in
situ hybridization to detect scl in control embryos (left), and in embryos
injected with smad5E4 RNA (middle) or smad5E4,5 RNA (right) at 12
hpf. Black arrowheads indicate the anterior limit of scl expression in the
ICM; open arrowheads mark scl expression in the RBI. Upper panel
shows dorsal views with anterior to the top; lower panel shows lateral
views with dorsal to the right. (G) Histogram showing the percentage of
injected embryos with wild-type (blue) or reduced (magenta) scl











As scl expression is also crucial for the formation of vascular
precursors, we examined the expression of the endothelial gene flk1
(kdrl – ZFIN) at various stages (de Jong and Zon, 2005; Liao et al.,
1997). We find that, although the early expression of flk1 is reduced
in ints5 morphants (Fig. 2C,D; see Fig. S3C in the supplementary
material), this seems to recover later, and by 24 hpf, with the
exception of the inter-segmental vessels, flk1 expression is detected
in most domains observed in control embryos (Fig. 2E-J). The lack
of flk1 expression in inter-segmental vessels might reflect cell
migration and/or vessel branching defects. These results suggest that
the common progenitor of hematopoietic and endothelial cells, the
hemangioblast precursors (Vogeli et al., 2006), are not affected in
ints5 morphants per se, and that Ints5 function is required for
hematopoietic development.
Ints5 is required for erythrocyte differentiation
A previous study by Qian et al. (Qian et al., 2007) showed that scl
isoforms function in the initiation of primitive hematopoiesis and
regulate erythroid cell differentiation. Since ints5 morpholino-
injected embryos have reduced scl expression, we examined
erythroid differentiation in Ints5-manipulated embryos. May-
Grunwald Giemsa staining of blood smears from wild-type
embryos revealed normal erythrocyte progenitors. These cells
differentiate and are typically categorized as: stage I, basophilic
erythroblast (30 hpf); stage II, polychromatophilic erythroblast (2
days post fertilization, dpf); stage III, orthochromatophilic
erythroblast (4 dpf); stage IV, erythrocyte (5 dpf onwards) (Fig. 3A-
C; data not shown), based on the shape of their nucleus, size and
morphology of the cells, and staining of the cytoplasm (Qian et al.,
2007).
Blood smear analysis showed that, whereas 98% of RBCs grow
to the polychromatophilic erythroblast stage (stage II) in control
embryos by 2 dpf (Fig. 3D,J), only 58% of RBCs in ints5 morphants
develop normally. In ints5 morphant embryos, 42% of cells arrested
at the basophilic erythroblast stage (stage I; Fig. 3E,J). To investigate
the role of Ints5 in RBC differentiation, we reduced the dosage of
the antisense morpholinos so as to allow embryos to survive to later
stages. At 7 dpf, only 30% of RBCs in ints5 morphant embryos
differentiated normally in comparison to control embryos in which
~80% of the cells are fully developed mature RBCs with flattened
elliptical shape (Fig. 3G,H,K). Normal differentiation of RBCs in
ints5 morphants was restored by co-injection of ints5 RNA (Fig.
3F,I,J,K). Thus, Ints5 function is required for the differentiation of
erythrocytes.
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Fig. 5. The hematopoiesis defects induced by Ints5 knockdown are rescued by smad1 and smad5 RNA. (A-L) Whole-mount in situ
hybridization to detect scl expression in 12 hpf embryos injected with control morpholinos (A,B), ints5 morpholinos (C,D), smad1 RNA (E,F), smad5
RNA (G,H), ints5 morpholinos with smad1 RNA (I,J), or ints5 morpholinos with smad5 RNA (K,L). Black arrowheads indicate the anterior limit of scl
expression in the ICM; open arrowheads indicate scl expression in the RBI. A,C,E,G,I,K show dorsal views of embryos with anterior to the top;
B,D,F,H,J,L show lateral views of embryos with dorsal to the right. (M) Histogram showing the percentage of injected embryos with wild-type-like
(blue) or reduced (magenta) scl expression. The total number of embryos for each staining is >180, and all experiments were carried out three
independent times (see Table S1 in the supplementary material). (N-S) May-Grunwald Giemsa staining to show RBC differentiation in embryos
injected with control morpholinos (N), ints5 morpholinos (O), smad1 RNA (P), smad5 RNA (Q), ints5 morpholinos with smad1 RNA (R), or ints5
morpholinos with smad5 RNA (S) at 2 dpf. (T) Histogram showing the percentage of RBCs with normal (blue) or arrested (magenta) differentiation
in injected embryos at 2 dpf. The total number of red blood cells counted for each sample is >200, and all experiments were carried out three











Ints5 is necessary for splicing of smad1 and smad5
transcripts
The Integrator complex is thought to be involved in snRNA
processing (Baillat et al., 2005). As ints5 morpholino-injected
embryos have decreased scl expression, similar to smad5 mutant
embryos (McReynolds et al., 2007), we investigated whether the
splicing of smad5 and smad1 is disrupted in ints5 morphant
embryos. Splicing of smad2, smad3a, smad3b, cyclops (ndr2 –
ZFIN), squint (ndr1 – ZFIN) and actin (bactin1 – ZFIN) RNAs
was also examined as controls. Total RNA was extracted from
embryos injected with control or ints5 splice morpholinos, and
RT-PCR was performed with primers for the various genes (Fig.
4A). In ints5 morpholino-injected embryos, as early as gastrula
stages we detected significant amounts of aberrantly spliced
smad5 transcripts that either lacked exon 4 or both exon 4 and
exon 5 (Fig. 4B,C). To test the activity of the aberrant smad5
splice products, we overexpressed capped synthetic mRNA
encoding Smad5 lacking exon 4 (smad5Δexon4), or exons 4 and
5 (smad5Δexon4,5). Analysis of scl expression showed that
embryos injected with smad5Δexon4 or smad5Δexon4,5 RNA
have reduced expression, similar to ints5 morphants (Fig. 4F,G).
Furthermore, western blot analysis using antibodies to detect
Smad5 protein in embryo extracts showed that the ints5
morpholinos disrupted the synthesis of Smad5 proteins and led to
the accumulation of truncated Smad5 proteins. The truncated
Smad5 proteins correspond to proteins encoded by the aberrant
transcripts, smad5Δexon4 and smad5Δexon4,5 (see Fig. S4 in the
supplementary material). These truncated proteins might function
as dominant-negative peptides that disrupt Smad5 function during
development.
Similarly, unspliced smad1 transcripts are also detected in ints5
morpholino-injected embryos (Fig. 4D). However, we did not
observe aberrant splicing of any exon-intron boundary of smad2,
smad3a or smad3b transcripts, or other examined transcripts (Fig.
4E; see Fig. S5 in the supplementary material; data not shown).
These results show that Ints5 is specifically required for the correct
splicing of smad1 and smad5 RNA.
To understand the mechanism underlying the smad1/5 splicing
defects in ints5 morphants, we examined the expression and
processing of U1/U2 snRNA (see Fig. S6A in the supplementary
material). Semi-quantitative RT-PCR analysis showed an
accumulation of unprocessed primary U1/U2 snRNAs in ints5
morpholino-injected embryos (see Fig. S6B,C,D in the
supplementary material). In contrast to the increased primary
U1/U2 snRNAs, the level of mature U1/U2 snRNAs was not
significantly altered in ints5 morphants (see Fig. S6E,F in the
supplementary material). These results show that Ints5 regulation
of smad1/5 RNA splicing is mediated via U1/U2 snRNA
processing.
Ints5 modulates hematopoiesis through
Smad/BMP signaling
To determine the epistatic relationship between Ints5 and Smad1 or
Smad5, we injected 10 pg of capped smad1 or smad5 RNA together
with ints5 morpholinos into 1-cell-stage embryos. We found that co-
injected smad1 or smad5 RNA could restore scl expression and RBC
differentiation in ints5 morphants, similar to ints5 RNA co-
injections (Fig. 5C,D,I-L,M,O,R,S,T; see Fig. S7B,E,F in the
supplementary material; see Table S1 in the supplementary material;
P0.01). Control embryos injected with 10 pg of smad1 or smad5
RNA alone showed normal scl expression and RBC differentiation
(Fig. 5E-H,M,P,Q,T; see Fig. S7C,D in the supplementary material),
similar to those injected with control morpholinos (Fig.
5A,B,M,N,T; see Fig. S7A in the supplementary material). Blood
circulation was also restored in ints5 morphants upon rescue with
smad1 or smad5 RNA (data not shown). These results, together with
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Fig. 6. Multiple subunits of the Integrator complex regulate
primitive hematopoiesis. (A-I) Whole-mount in situ hybridization to
detect scl (A,B,D,E,G,H) and gata1 (C,F,I) expression in embryo injected
with control morpholinos (A-C), ints11 splice-junction morpholinos (S
MO, D-F) and ints9 splice-junction morpholinos (G-I). Black arrowhead
indicates the anterior limit of scl expression in the ICM. The ints9 and
ints11 morphants show substantially reduced scl and gata1 expression
in comparison to control morphants. (J,K) Histograms showing the
percentage of injected embryos with wild-type (blue) or reduced
(magenta) scl (J) and gata1 (K) expression levels. Scale bars: 50μm in










the results from semi-quantitative RT-PCR experiments (see Fig. S3
in the supplementary material), show that Ints5 functions in
hematopoiesis by modulating smad1/5 RNA splicing.
The Integrator complex regulates primitive
hematopoiesis
As Ints5 is a subunit of the Integrator complex (Baillat et al., 2005),
to find out whether Ints5 functions independently or as part of the
Integrator complex in regulating hematopoiesis, we examined the
activity of other Integrator subunits. We injected ints11 (zgc::110671
– ZFIN) ATG morpholinos and splice morpholinos targeting the
boundary of intron 4 and exon 5 in the ints11 gene into 1-cell-stage
embryos. Both ints11 morpholinos caused reduced expression of the
hematopoietic markers scl and gata1 (Fig. 6A-C,D-F,J,K; data not
shown) in more than 50% embryos. In addition, embryos injected
with ints9 (zgc::154012 – ZFIN) splice morpholinos targeting the
boundary of intron 2 and exon 3 showed similar hematopoiesis
defects (Fig. 6G-K). Morpholinos targeting the splice junction of
ints11 also caused defects in smad5 splicing, U1/U2 snRNA
processing and hematopoiesis (Figs 6 and 7; see Fig. S6B in the
supplementary material). Therefore, multiple subunits of the
Integrator complex, including Ints5, might be required for
appropriate hematopoietic gene expression. These results suggest
that the Integrator proteins function as a complex to regulate
primitive hematopoiesis by modulating smad1/5 splicing during
zebrafish development.
DISCUSSION
Although hematopoiesis has been extensively studied, the
molecular program of hematopoietic stem cell induction and self-
renewal remains unclear. Recent work has revealed that the post-
transcriptional processing of BMP Smads is involved in the
maintenance of hematopoietic stem cell identity. Jiang et al.
identified a C-terminal truncation in SMAD5, SMAD5β, which
inactivates the protein. SMAD5β is expressed in both normal
hematopoiesis and leukemogenesis (Jiang et al., 2000).
Interestingly, the expression level of the SMAD5β isoform is
higher in CD34+ hematopoietic stem cells than in terminally
differentiated peripheral blood leukocytes, indicating that the
alternative splicing of SMAD5 is differentially regulated during the
maturation of hematopoietic cells. Our work shows that the
splicing of smad1/5 is impaired by the knockdown of Ints5.
Aberrant splicing of smad5 leads to the production of dominant-
negative forms of Smad5, the overexpression of which
phenocopies the hematopoiesis phenotypes we observed in ints5
morphants. These include reduced the expression of scl and,
eventually, failure in erythrocyte differentiation. Thus, the accurate
splicing of smad5 is crucial for the normal progression of
hematopoiesis and erythropoietic differentiation, and the failure to
generate appropriate Smad5 products can lead to a reduction of
hematopoietic progenitors.
The analysis of germ-layer specification and dorsoventral
patterning suggests that these developmental processes are not
affected in ints5 morphant embryos. In addition, the expression of
pax2a, spt, myoD and ntl suggests that anterior-posterior patterning
is also largely normal (Fig. 2B; see Fig. S2F, Fig. S7B and Fig. S9C
in the supplementary material). It may seem surprising that, although
Ints5 knockdown affects smad1/5 splicing, we do not observe early
dorsoventral or anterior-posterior patterning, or germ-layer
specification defects (see Fig. S2 in the supplementary material), as
observed for smad5 and other BMP pathway mutants (Dick et al.,
2000; Hild et al., 1999; Kishimoto et al., 1997; Kodjabachian et al.,
1999; Mullins et al., 1996; Schmid et al., 2000; Schulte-Merker et
al., 1997). This can be explained by the maternal deposition of
Integrator complex factors such as Ints5 (see Fig. S8 in the
supplementary material). The maternal Ints products might allow
normal functioning of the Integrator complex in early embryos, such
that the early patterning events that are mediated by BMP signaling
are not affected by the knockdown of Ints5. We also observe
convergent-extension defects in ints5 morphants (Fig 1E; see Fig.
S2E,F,I,J and Fig. S9C,D,M in the supplementary material), leading
to a shortened anterior-posterior axis in ints5 morphants. It is
possible that the Integrator subunits also regulate cell movements
via Smad1/5 signaling, as co-injection of smad1/5 RNA can restore
normal cell movements in ints5 morphants (see Fig. S9I-L,M in the
supplementary material).
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Fig. 7. Knockdown of ints11
perturbs smad5 splicing. (A) RT-PCR
analysis shows that the ints11 splice-
junction morpholino efficiently blocks
the correct splicing of ints11 RNA, and
several aberrant transcripts are detected.
Transcripts are indicated by black
arrows, with sizes indicated.
(B) Schematic representation of the
ints11 genomic locus (upper panel);
schematic representation of normal or
aberrant ints11 transcripts is shown in
the lower panel. Numbered black
arrows indicate the position of primers
used in RT-PCRs to detect splicing.
Orange bar shows the target site of the
ints11 splice-site morpholino. (C) RT-PCR
analysis shows that splicing of smad5 is
impaired in ints11 morphants.
(D) Schematic representation of the
smad5 genomic locus (upper panel); the
lower panel shows schematic
representations of normal and












One interesting question is how the Integrator complex proteins,
which are thought to function in RNA processing, might have such
a specific effect on Smad/BMP signaling and hematopoiesis. Only
smad1 and smad5 splicing is affected, whereas the expression of
other Smads (e.g. smad2, smad3a and smad3b) is not disrupted,
suggesting that the Integrator complex does not generally affect all
splicing. Furthermore, our analysis of several genes [chordin, vent,
vox, ved, gata2a, eve1, smurf1 (wwp1 – ZFIN), bmp2b, bmp7a, ski
(skia – ZFIN), sqt, cyc and others] shows that the disruption of
Integrator complex function does not generally affect genes
expressed during gastrulation. This raises the possibility that the
Integrator complex might be functioning specifically in the cells that
respond to BMP signaling.
It is now known that mutations affecting some transcription or
translation machinery components can have very specific effects
on distinct cell types (Pellizzoni, 2007; van der Knaap et al., 2006).
Recent work by Watanabe et al. has shown that Sf3b4, a subunit of
Sf3b, which is a common RNA splicing complex, specifically
binds to Bmpr1a and inhibits BMP signaling during osteochondral
cell differentiation (Watanabe et al., 2007). There might be a
potential connection between TGFβ/BMP signaling and the RNA
processing machinery. So it is possible that Ints5, which is
involved in U1/U2 snRNA maturation, which in turn is important
for pre-mRNA splicing, might cooperate with other RNA splicing
factors in specific cellular contexts (such as in hematopoietic
progenitors), to specifically modulate BMP signaling via
smad1/smad5 RNA splicing. Alternatively, Ints5 itself might be
post-transcriptionally regulated via factors that are specific to
hematopoietic progenitors.
Deficiencies in RNA splicing have been shown to cause many
genetic disorders (Pellizzoni, 2007; Solis et al., 2008). As the
Integrator complex plays a vital role in the transcription and
processing of snRNA, dysfunction of the Integrator subunits can
lead to various developmental defects. In fact, recent work has
shown that disruption of the murine integrator complex subunit 1
causes growth arrest and eventual apoptosis at early blastocyst
stages (Hata and Nakayama, 2007). Integrator subunit 3 is a
probable target for the amplification of chromosomal region 1q21
found in most hepatocellular carcinoma (HCC) tumors, and may be
involved in the development and/or progression of this cancer
(Inagaki et al., 2008). However, it is still unclear how these genes
function, and how their malfunction leads to profound defects in
specific biological processes. The study presented here reveals a
potential link between snRNA processing and BMP signaling in
hematopoiesis. Understanding the precise mechanisms by which the
individual subunits function may provide insights into the roles
played by the Integrator complex during development and
tumorigenesis.
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